{"content":"<li class=\"n-box-item date-title\" data-end=\"1520312399\" data-start=\"1520226000\" data-txt=\"Monday, December 23, 2019\">Monday, March  5, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3336621\" data-ts=\"1520296422\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCYX\" target=\"_blank\">SCYX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336621-scynexisminus-9_6-on-planned-offering-of-shares-warrants\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Scynexis -9.6% on planned offering of shares, warrants</a></h4><ul>   <li>Scynexis (NASDAQ:<a href='https://seekingalpha.com/symbol/SCYX' title='SCYNEXIS, Inc.'>SCYX</a>) has <font color='red'>slid 9.6%</font> after hours on news it's <a href=\"https://seekingalpha.com/pr/17092353-scynexis-announces-launch-public-offering-common-stock-warrants\" target=\"_blank\">launching a public offering</a> of common shares and warrants.</li>    <li>The company's selling all shares and warrants. The sole-book-runner is Guggenheim.</li>    <li>Shares are indicating a 52-week low with the news; they're already <font color='red'>down 27.2%</font> YTD but are slightly better than flat over the past month.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3336621\" data-linked=\"Scynexis -9.6% on planned offering of shares, warrants\" data-tweet=\"$SCYX - Scynexis -9.6% on planned offering of shares, warrants https://seekingalpha.com/news/3336621-scynexisminus-9_6-on-planned-offering-of-shares-warrants?source=tweet\" data-url=\"https://seekingalpha.com/news/3336621-scynexisminus-9_6-on-planned-offering-of-shares-warrants\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336620\" data-ts=\"1520296106\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GNCA\" target=\"_blank\">GNCA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336620-genocea-jumps-17_5-cantor-sees-five-bagger-potential\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Genocea jumps 17.5% as Cantor sees five-bagger potential</a></h4><ul>   <li>Amid a spate of recent price target cuts, Genocea Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/GNCA' title='Genocea Biosciences, Inc.'>GNCA</a>) is <font color='green'>up 17.5%</font> on heavy volume after hours following an initiation at Overweight by Cantor Fitzgerald.</li>    <li>The firm set a Street-high price target of $5, suggesting a near-quintupling from today's close of $1.03.</li>    <li>Shares finished <font color='green'>up 2%</font> during the regular session; they're <font color='red'>down 11.2%</font> so far in 2018.</li><li><strong>Update</strong>: Shares are up&nbsp;<font color='green'>25%</font>&nbsp;premarket on robust volume on Tuesday, March 6.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3336620\" data-linked=\"Genocea jumps 17.5% as Cantor sees five-bagger potential\" data-tweet=\"$GNCA - Genocea jumps 17.5% as Cantor sees five-bagger potential https://seekingalpha.com/news/3336620-genocea-jumps-17_5-cantor-sees-five-bagger-potential?source=tweet\" data-url=\"https://seekingalpha.com/news/3336620-genocea-jumps-17_5-cantor-sees-five-bagger-potential\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336606\" data-ts=\"1520289353\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TNTR-OLD\" target=\"_blank\">TNTR-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336606-after-hours-gainers-losers-3-5-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers (3/5/2018)</a></h4><ul>     <li><b>Top gainers:</b> <a href='https://seekingalpha.com/symbol/TNTR-OLD' title='Tintri, Inc.'>TNTR-OLD</a> <font color='green'>+10.7%</font>. <a href='https://seekingalpha.com/symbol/TEDU' title='Tarena International, Inc.'>TEDU</a> <font color='green'>+6.3%</font>. <a href='https://seekingalpha.com/symbol/NMZ' title='Nuveen Municipal High Income Opportunity Fund'>NMZ</a> <font color='green'>+3.6%</font>. <a href='https://seekingalpha.com/symbol/LOMA' title='Loma Negra Compania Industrial Argentina Sociedad  ADS'>LOMA</a> <font color='green'>+2.9%</font>. <a href='https://seekingalpha.com/symbol/BRFS' title='BRF-Brasil Foods S.A.'>BRFS</a> <font color='green'>+1.5%</font>.</li><li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/GLYC' title='GlycoMimetics'>GLYC</a> <font color='red'>-20.0%</font>. <a href='https://seekingalpha.com/symbol/FRPT' title='Freshpet'>FRPT</a> <font color='red'>-12.9%</font>. <a href='https://seekingalpha.com/symbol/ASNA' title='Ascena Retail Group Inc'>ASNA</a> <font color='red'>-12.4%</font>. <a href='https://seekingalpha.com/symbol/STRL' title='Sterling Construction Company Inc'>STRL</a> <font color='red'>-3.9%</font>. <a href='https://seekingalpha.com/symbol/JWN' title='Nordstrom Inc.'>JWN</a> <font color='red'>-2.5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3336606\" data-linked=\"After Hours Gainers / Losers (3/5/2018)\" data-tweet=\"$TNTR-OLD $TNTR-OLD $TEDU - After Hours Gainers / Losers (3/5/2018) https://seekingalpha.com/news/3336606-after-hours-gainers-losers-3-5-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3336606-after-hours-gainers-losers-3-5-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336605\" data-ts=\"1520289336\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YY\" target=\"_blank\">YY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336605-yyplus-2_9-strong-revenue-profit-growth-mark-q4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">YY +2.9% as strong revenue, profit growth mark Q4</a></h4><ul>   <li><a href='https://seekingalpha.com/symbol/YY' title='YY Inc.'>YY</a> is <font color='green'>up 2.9%</font> in postmarket trading after a solid beat with <a href=\"https://seekingalpha.com/news/3336587-yy-beats-0_43-beats-revenue\" target=\"_blank\">Q4 earnings</a> that shows 46% revenue growth and stronger profitability.</li>    <li>Net income attributable to YY (non-GAAP) rose by 58.5% to 948.9M yuan -- about $145.8M.</li>    <li>Revenue gains were driven mainly by an increase in live streaming, which grew 51.9%. Revenues from online games ticked up to 128.1M yuan from 125.4M yuan, while revenue from memberships fell to 50.5M yuan from 74.7M.</li>    <li>Gross profit rose 54.7%, and gross margin rose to 39.4% from 37.2%.</li>    <li>In Q4, net cash from operations was 1.392B yuan (about $213.9M).</li>    <li>As of year-end, it had cash and equivalents of 2.62B yuan (about $402.3M), along with short-term deposits of another $922M and restricted short-term deposits of $153.7M.</li>    <li>For Q1, it's expecting revenues of 3B-3.15B yuan (Y/Y growth of 32.3%-39%); in dollar terms, that would be $472.5M-$496.2M, vs. consensus for $478.6M.</li>    <li><a href=\"http://ir.yy.com/\" target=\"_blank\">Conference call</a> to come at 8 p.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/17092507-yy-reports-fourth-quarter-full-year-2017-unaudited-financial-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3336605\" data-linked=\"YY +2.9% as strong revenue, profit growth mark Q4\" data-tweet=\"$YY - YY +2.9% as strong revenue, profit growth mark Q4 https://seekingalpha.com/news/3336605-yyplus-2_9-strong-revenue-profit-growth-mark-q4?source=tweet\" data-url=\"https://seekingalpha.com/news/3336605-yyplus-2_9-strong-revenue-profit-growth-mark-q4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336599\" data-ts=\"1520288262\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FRPT\" target=\"_blank\">FRPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336599-light-guidance-sends-freshpet-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Light guidance sends Freshpet lower</a></h4><ul> <li>Shares of Freshpet (NASDAQ:<a href='https://seekingalpha.com/symbol/FRPT' title='Freshpet'>FRPT</a>)&nbsp;<font color='red'>peel off 14%</font>&nbsp;in AH trading after Q4 numbers fall just slightly short of estimates.</li> <li>The selling pressure seems to be tied to the company's annual guidance, which set a low point light of consensus marks. Freshpet sees FY18 revenue of greater than $185M vs. $188M consensus and adjusted EBITDA of greater than $20M vs. $22.3M expected.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3336536-freshpet-misses-0_01-misses-revenue\" target=\"_blank\">Freshpet misses by $0.01, misses on revenue</a> (March 5)</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3336599\" data-linked=\"Light guidance sends Freshpet lower\" data-tweet=\"$FRPT - Light guidance sends Freshpet lower https://seekingalpha.com/news/3336599-light-guidance-sends-freshpet-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/3336599-light-guidance-sends-freshpet-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:17 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336592\" data-ts=\"1520287745\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASNA\" target=\"_blank\">ASNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336592-margins-disappoint-ascena-retail\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Margins disappoint at Ascena Retail</a></h4><ul>     <li>Ascena Retail (NASDAQ:<a href='https://seekingalpha.com/symbol/ASNA' title='Ascena Retail Group Inc'>ASNA</a>) is down sharply after posting a larger loss than anticipated in FQ2.</li>     <li>Comparable sales fell 2% during the period.</li>     <li>Comparable sales by brands:&nbsp;Justice comparable sales +7%, Maurices -5%, Dressbarn&nbsp; -12%. Catherines -5%.</li><li>Gross margin came in a 54.1% of sales to fall below the expectation of analysts and the guidance issued by Ascena in December.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3336540-ascena-retail-group-misses-0_03-beats-revenue\" target=\"_blank\">Ascena Retail Group misses by $0.03, beats on revenue</a> (March 5)</li><li>ASNA&nbsp;<font color='red'>-16.53%</font>&nbsp;AH to $2.02.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3336592\" data-linked=\"Margins disappoint at Ascena Retail\" data-tweet=\"$ASNA - Margins disappoint at Ascena Retail https://seekingalpha.com/news/3336592-margins-disappoint-ascena-retail?source=tweet\" data-url=\"https://seekingalpha.com/news/3336592-margins-disappoint-ascena-retail\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336577\" data-ts=\"1520286685\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336577-piper-jaffray-survey-shows-why-iphone-owners-didnt-want-x\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Piper Jaffray survey shows why iPhone owners didn&#39;t want X</a></h4><ul><li>Piper Jaffray <a href=\"https://www.fastcompany.com/40539648/this-is-why-a-lot-of-iphone-users-havent-upgraded-to-the-iphone-x?partner=feedburner&amp;utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+fastcompany%2Fheadlines+%28Fast+Company%29\" target=\"_blank\">releases a new survey</a> asking why people who currently own Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) iPhones didn&rsquo;t upgrade to the iPhone X.</li><li>The answers: 31%, &ldquo;it&rsquo;s too expensive&rdquo;; 44%, &ldquo;my iPhone works fine&rdquo;; 8%, &ldquo;I prefer a larger screen.&rdquo;</li><li>The three iPhone models rumored to release this year include a more cost-friendly version of the X and a larger, phablet version.</li><li>Apple shares are&nbsp;<font color='red'>down 0.2%</font>&nbsp;aftermarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3336319-apple-planning-cheaper-macbook-air-branded-headphones-year\" target=\"_blank\">Apple planning cheaper MacBook Air, branded headphones this year?</a> (March 5)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3336328-apple-supplier-finisar-will-start-production-new-plant-october\" target=\"_blank\">Apple supplier Finisar will start production at new plant in October</a> (March 5)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3336411-dialog-semiconductor-says-apple-contract-stretches-2020\" target=\"_blank\">Dialog Semiconductor says Apple contract stretches into 2020</a> (March 5)</li><li>Updating to note that the survey included <a href=\"https://www.barrons.com/articles/apple-survey-says-people-want-cheaper-bigger-iphone-says-piper-1520259215\" target=\"_blank\">1,500 respondents </a>who own an iPhone but haven't recently updated.</li></ul><div class=\"tiny-share-widget\" data-id=\"3336577\" data-linked=\"Piper Jaffray survey shows why iPhone owners didn&#39;t want X\" data-tweet=\"$AAPL - Piper Jaffray survey shows why iPhone owners didn&#39;t want X https://seekingalpha.com/news/3336577-piper-jaffray-survey-shows-why-iphone-owners-didnt-want-x?source=tweet\" data-url=\"https://seekingalpha.com/news/3336577-piper-jaffray-survey-shows-why-iphone-owners-didnt-want-x\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>378&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336573\" data-ts=\"1520286492\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEDU\" target=\"_blank\">TEDU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336573-tarena-misses-rmb0_18-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tarena misses by RMB0.18, beats on revenue</a></h4><ul><li>Tarena (NASDAQ:<a href='https://seekingalpha.com/symbol/TEDU' title='Tarena International, Inc.'>TEDU</a>): Q4 EPS of RMB1.74 <font color='red'>misses by RMB0.18</font>.</li><li>Revenue of RMB617M (+33.0% Y/Y) <font color='green'>beats by RMB23.67M</font>.</li><li>Shares <font color='green'>+2.2%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17092466-tarena-international-inc-announces-results-fourth-quarter-2017-fiscal-year-2017\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3336573\" data-linked=\"Tarena misses by RMB0.18, beats on revenue\" data-tweet=\"$TEDU - Tarena misses by RMB0.18, beats on revenue https://seekingalpha.com/news/3336573-tarena-misses-rmb0_18-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3336573-tarena-misses-rmb0_18-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:48 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336572\" data-ts=\"1520286281\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PARR\" target=\"_blank\">PARR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336572-par-pacific-beats-0_35-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Par Pacific beats by $0.35, beats on revenue</a></h4><ul><li>Par Pacific (NYSEMKT:<a href='https://seekingalpha.com/symbol/PARR' title='Par Pacific Holdings, Inc.'>PARR</a>): Q4 EPS of $0.53 <font color='green'>beats by $0.35</font>.</li><li>Revenue of $663.1M (+17.8% Y/Y) <font color='green'>beats by $73.1M</font>.</li><li>Shares <font color='green'>+1.9%</font>.</li><li><a href='https://seekingalpha.com/pr/17092474-par-pacific-holdings-reports-strong-full-year-fourth-quarter-2017-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3336572\" data-linked=\"Par Pacific beats by $0.35, beats on revenue\" data-tweet=\"$PARR - Par Pacific beats by $0.35, beats on revenue https://seekingalpha.com/news/3336572-par-pacific-beats-0_35-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3336572-par-pacific-beats-0_35-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336569\" data-ts=\"1520286073\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOGO\" target=\"_blank\">GOGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336569-gogo-ceo-steps-down\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gogo CEO steps down</a></h4><ul><li>        Gogo (NASDAQ:<a href='https://seekingalpha.com/symbol/GOGO' title='Gogo'>GOGO</a>) Michael Small <a href=\"http://gogoair.mediaroom.com/2018-03-05-Gogo-Appoints-Oakleigh-Thorne-as-President-and-Chief-Executive-Officer\" target=\"_blank\">steps down</a> in a mutual decision with the board.</li><li>               Oakleigh Thorne steps in as the new President and CEO effective immediately. Thorne currently serves as CEO of Thorndale Farm, the family office and largest Gogo shareholder with a 30% stake.&nbsp;</li><li>               Thorne previously served as CEO at eCollege.com.&nbsp;</li><li>               Gogo shares are&nbsp;<font color='green'>up 0.13%</font>.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3336569\" data-linked=\"Gogo CEO steps down\" data-tweet=\"$GOGO - Gogo CEO steps down https://seekingalpha.com/news/3336569-gogo-ceo-steps-down?source=tweet\" data-url=\"https://seekingalpha.com/news/3336569-gogo-ceo-steps-down\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336565\" data-ts=\"1520285873\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JWN\" target=\"_blank\">JWN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336565-nordstromminus-2_7-rejects-family-offer-to-buy-company\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nordstrom -2.7% as it rejects family offer to buy company</a></h4><ul>   <li>Nordstrom (NYSE:<a href='https://seekingalpha.com/symbol/JWN' title='Nordstrom Inc.'>JWN</a>) is <font color='red'>2.7% lower</font> postmarket after it's noted it <a href=\"https://seekingalpha.com/pr/17092450-special-committee-nordstrom-board-announces-receipt-rejection-indicative-proposal-acquire\" target=\"_blank\">received -- and rejected</a> -- an indicative proposal from the Nordstrom family to acquire the company.</li>    <li>A group consisting of company Co-Presidents Blake Nordstrom, Peter Nordstrom, and Erik Nordstrom, along with President of Stores James Nordstrom, Chairman Emeritus Bruce Nordstrom, and Anne E. Gittinger said it intended to submit a proposal to buy all outstanding shares it doesn't already own along with 21% of family-owned shares for $50 each, the company says.</li><li>Shares closed today at $51.90.</li><li>A special committee of Nordstrom's board rejected the offer.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3333940-nordstrom-family-looking-seal-go-private-deal\" target=\"_blank\">Nordstrom family looking to seal go-private deal</a> (Feb. 23 2018)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3336565\" data-linked=\"Nordstrom -2.7% as it rejects family offer to buy company\" data-tweet=\"$JWN - Nordstrom -2.7% as it rejects family offer to buy company https://seekingalpha.com/news/3336565-nordstromminus-2_7-rejects-family-offer-to-buy-company?source=tweet\" data-url=\"https://seekingalpha.com/news/3336565-nordstromminus-2_7-rejects-family-offer-to-buy-company\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336556\" data-ts=\"1520285322\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TNTR-OLD\" target=\"_blank\">TNTR-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336556-tintriplus-12_7-on-q4-beats-mixed-guidance-ceo-transition\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tintri +12.7% on Q4 beats, mixed guidance, CEO transition</a></h4><ul><li>        Tintri (NASDAQ:<a href='https://seekingalpha.com/symbol/TNTR-OLD' title='Tintri, Inc.'>TNTR-OLD</a>) shares&nbsp;<font color='green'>soar 12.7%</font>&nbsp;aftermarket following a Q4 report that beat EPS and revenue estimates and included mixed guidance and a CEO transition announcement.</li><li>               Q1 guidance has downside revenue of $20M to $21M (consensus: $25.05) and upside EPS from -$0.68 to -$0.64 (consensus: -$0.74).&nbsp;</li><li>               CEO change: The company announces that Chairman and CEO Ken Klein will step down once a successor is found and transitioned into the role. Tintri hired an executive search firm to help find Klein&rsquo;s replacement.&nbsp;</li><li>                  Promissory notes financing: The company announced last week the issuance of promissory notes to certain stockholders for gross proceeds of $25M. The notes have an interest rate of 8% per annum and mature 18 months from date of issuance. &nbsp;   </li><li>                  Restructuring. Tintri&rsquo;s restructuring will reduce the global workforce by 20%. Last month, the company announced the early termination of a facility lease. Company expects restructuring to mostly finish by Q1 of FY18, which ends on April 30. Incurred cash expenditures expected to total $4.8M to $5.9M with total restructuring expenses from $6.2M to $7.2M.    </li><li>               Earnings call is scheduled for 4:30 PM ET with a webcast available <a href=\"https://ir.tintri.com/\" target=\"_blank\">here</a>.&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/17092380-tintri-reports-fourth-quarter-fiscal-year-2018-financial-results\" target=\"_blank\">Press release</a>&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3336532-tintri-beats-0_08-beats-revenue\" target=\"_blank\">Tintri beats by $0.08, beats on revenue</a> (March 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3336556\" data-linked=\"Tintri +12.7% on Q4 beats, mixed guidance, CEO transition\" data-tweet=\"$TNTR-OLD - Tintri +12.7% on Q4 beats, mixed guidance, CEO transition https://seekingalpha.com/news/3336556-tintriplus-12_7-on-q4-beats-mixed-guidance-ceo-transition?source=tweet\" data-url=\"https://seekingalpha.com/news/3336556-tintriplus-12_7-on-q4-beats-mixed-guidance-ceo-transition\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336548\" data-ts=\"1520284809\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HAIR\" target=\"_blank\">HAIR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336548-restoration-robotics-beats-0_12-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Restoration Robotics beats by $0.12, beats on revenue</a></h4><ul><li>Restoration Robotics (NASDAQ:<a href='https://seekingalpha.com/symbol/HAIR' title='Restoration Robotics'>HAIR</a>): Q4 EPS of -$0.04 <font color='green'>beats by $0.12</font>.</li><li>Revenue of $5.85M (+13.2% Y/Y) <font color='green'>beats by $0.08M</font>.</li><li>Shares <font color='green'>+5.62%</font>.</li><li><a href='https://seekingalpha.com/pr/17092364-restoration-robotics-reports-financial-results-fourth-quarter-full-year-2017'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3336548\" data-linked=\"Restoration Robotics beats by $0.12, beats on revenue\" data-tweet=\"$HAIR $VERO - Restoration Robotics beats by $0.12, beats on revenue https://seekingalpha.com/news/3336548-restoration-robotics-beats-0_12-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3336548-restoration-robotics-beats-0_12-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336547\" data-ts=\"1520284783\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GTHX\" target=\"_blank\">GTHX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336547-g1-therapeutics-readies-3m-share-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">G1 Therapeutics readies 3M-share stock offering</a></h4><ul><li>G1 Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/GTHX' title='G1 Therapeutics'>GTHX</a>) files a <a href=\"https://www.sec.gov/Archives/edgar/data/1560241/000119312518070501/d507211ds1.htm\" target=\"_blank\">prospectus </a>for a public offering of 3M shares of common stock. Price and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3336547\" data-linked=\"G1 Therapeutics readies 3M-share stock offering\" data-tweet=\"$GTHX - G1 Therapeutics readies 3M-share stock offering https://seekingalpha.com/news/3336547-g1-therapeutics-readies-3m-share-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3336547-g1-therapeutics-readies-3m-share-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336523\" data-ts=\"1520282638\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVGO\" target=\"_blank\">AVGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336523-bloomberg-broadcom-on-course-to-win-qualcomm-board\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bloomberg: Broadcom on course to win Qualcomm board</a></h4><ul><li>        Bloomberg obtains information showing that <a href=\"https://www.bloomberg.com/news/articles/2018-03-05/broadcom-is-on-course-to-win-majority-of-qualcomm-board-seats\" target=\"_blank\">at least half the votes</a> already cast were in favor of Broadcom&rsquo;s (NASDAQ:<a href='https://seekingalpha.com/symbol/AVGO' title='Broadcom Limited'>AVGO</a>) nominees for Qualcomm&rsquo;s (NASDAQ:<a href='https://seekingalpha.com/symbol/QCOM' title='Qualcomm Inc.'>QCOM</a>) board.</li><li>               This story is developing and will update when more information becomes available.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3336272-cfius-delays-qualcomm-shareholder-meeting\" target=\"_blank\">CFIUS delays Qualcomm shareholder meeting</a> (March 5)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3336372-broadcom-responds-cfius-investigation-delayed-qualcomm-meeting\" target=\"_blank\">Broadcom responds to CFIUS investigation, delayed Qualcomm meeting</a> (March 5)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3336435-qualcomm-says-broadcom-knew-cfius-investigation\" target=\"_blank\">Qualcomm says Broadcom knew about CFIUS investigation</a> (March 5)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3336507-bloomberg-qcom-investor-t-rowe-price-voted-broadcom-nominees\" target=\"_blank\">Bloomberg: QCOM investor T. Rowe Price voted for Broadcom nominees</a> (March 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3336523\" data-linked=\"Bloomberg: Broadcom on course to win Qualcomm board\" data-tweet=\"$AVGO $AVGO $QCOM - Bloomberg: Broadcom on course to win Qualcomm board https://seekingalpha.com/news/3336523-bloomberg-broadcom-on-course-to-win-qualcomm-board?source=tweet\" data-url=\"https://seekingalpha.com/news/3336523-bloomberg-broadcom-on-course-to-win-qualcomm-board\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>165&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336522\" data-ts=\"1520282472\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TROV\" target=\"_blank\">TROV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336522-trovagene-up-21-on-early-results-form-pmcminus-075-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TrovaGene up 21% on early results form PMC-075 study</a></h4><ul><li>Nano cap TrovaGene (<a href='https://seekingalpha.com/symbol/TROV' title='TrovaGene, Inc.'>TROV</a> <font color='green'>+21.1%</font>) is up on 80% higher volume. This morning, it <a href=\"https://seekingalpha.com/pr/17091482-trovagene-announces-first-patient-successfully-completes-cycle-1-treatment-pcmminus-075\" target=\"_blank\">announced </a>that the first patient has completed cycle 1 in its open-label Phase 1b/2 clinical trial assessing PCM-075, in combination with low-dose cytarabine, in patients with acute myeloid leukemia &#40;AML&#41;.</li><li>By day 15 of the treatment cycle, the patient experienced a decrease in blood leukemic cells to 5% from 40%. In addition, the patient tolerated PCM-075 well.</li><li>PCM-075 inhibits an enzyme called serine/threonine polo-like-kinase 1 (PLK 1) which is overexpressed in a range of blood cancers and solid tumors. Studies have shown that inhibiting polo-like-kinases can lead to cancer cell death.</li></ul><div class=\"tiny-share-widget\" data-id=\"3336522\" data-linked=\"TrovaGene up 21% on early results form PMC-075 study\" data-tweet=\"$TROV - TrovaGene up 21% on early results form PMC-075 study https://seekingalpha.com/news/3336522-trovagene-up-21-on-early-results-form-pmcminus-075-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3336522-trovagene-up-21-on-early-results-form-pmcminus-075-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336520\" data-ts=\"1520282131\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DDD\" target=\"_blank\">DDD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336520-susquehanna-raises-3d-systems-target-to-13-downside-sharesplus-9_6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Susquehanna raises 3D Systems target to 13% downside; shares +9.6%</a></h4><ul><li>        Susquehanna maintains a Neutral rating on 3D Systems (NYSE:<a href='https://seekingalpha.com/symbol/DDD' title='3D Systems Corp.'>DDD</a>) and increases the price target by a dollar to $10, a 13% downside to Friday&rsquo;s close.</li><li>               Analyst David Ryzhik found preliminary Q4 results encouraging but says it&rsquo;s too soon to call this a turnaround.&nbsp;</li><li>                  The analyst expects 3D to take more than a quarter to iron out execution issues and it&rsquo;s too early to predict the performance of new products.    </li><li>               Source: Bloomberg First Word.&nbsp;</li><li>               3D Systems shares are&nbsp;<font color='green'>up 9.6%</font>&nbsp;to $12.58 with a 52-week range of $7.92 to $23.70.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3335408-3d-systems-plus-14_7-percent-delaying-q4-report-includes-upside-prelim-results\" target=\"_blank\">3D Systems +14.7% after delaying Q4 report, includes upside prelim results</a> (Feb. 28)</li></ul><div class=\"tiny-share-widget\" data-id=\"3336520\" data-linked=\"Susquehanna raises 3D Systems target to 13% downside; shares +9.6%\" data-tweet=\"$DDD - Susquehanna raises 3D Systems target to 13% downside; shares +9.6% https://seekingalpha.com/news/3336520-susquehanna-raises-3d-systems-target-to-13-downside-sharesplus-9_6?source=tweet\" data-url=\"https://seekingalpha.com/news/3336520-susquehanna-raises-3d-systems-target-to-13-downside-sharesplus-9_6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336516\" data-ts=\"1520281230\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XLF\" target=\"_blank\">XLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336516-stocks-surge-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stocks surge higher</a></h4><ul><li>Stocks continue to bounce big from lows hit early Friday morning, with the S&amp;P 500&nbsp;<font color='green'>adding another 1.4%</font>&nbsp;today. The Dow's<font color='green'> up 1.5%</font>&nbsp;and Nasdaq&nbsp;<font color='green'>1.1%</font>.</li><li>It's a broad rally, but the financials (<a href='https://seekingalpha.com/symbol/XLF' title='Financial Select Sector SPDR ETF'>XLF</a> <font color='green'>+1.7%</font>) are leading. Helping is an on-fire insurance sector<a href=\"https://seekingalpha.com/news/3336337-axa-expands-insurance-business-15_3b-xl-takeover\" target=\"_blank\"> following the sale of </a>XL Group at a 33% premium.</li></ul><div class=\"tiny-share-widget\" data-id=\"3336516\" data-linked=\"Stocks surge higher\" data-tweet=\"$XLF - Stocks surge higher https://seekingalpha.com/news/3336516-stocks-surge-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/3336516-stocks-surge-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336515\" data-ts=\"1520280769\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TZOO\" target=\"_blank\">TZOO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336515-travelzoo-authorizes-share-repurchase-shares-1_2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Travelzoo authorizes share repurchase; shares - 1.2%</a></h4><ul><li>        Travelzoo&rsquo;s (NASDAQ:<a href='https://seekingalpha.com/symbol/TZOO' title='Travelzoo Inc'>TZOO</a>) board <a href=\"https://seekingalpha.com/pr/17092289-travelzoo-announces-share-repurchase-program\" target=\"_blank\">authorizes the repurchase</a> of up to 500K shares of common stock.</li><li>               Purchases will be funded from available cash.&nbsp;</li><li>               Travelzoo shares are&nbsp;<font color='red'>down 1.2%</font>&nbsp;to $6.10.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3336515\" data-linked=\"Travelzoo authorizes share repurchase; shares - 1.2%\" data-tweet=\"$TZOO - Travelzoo authorizes share repurchase; shares - 1.2% https://seekingalpha.com/news/3336515-travelzoo-authorizes-share-repurchase-shares-1_2?source=tweet\" data-url=\"https://seekingalpha.com/news/3336515-travelzoo-authorizes-share-repurchase-shares-1_2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:12 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336514\" data-ts=\"1520280573\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MCF\" target=\"_blank\">MCF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336514-contango-oilplus-6-q4-output-hits-guidance-despite-weather-problems\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Contango Oil +6% as Q4 output hits guidance despite weather problems</a></h4><ul>     <li>Contango Oil &amp;&nbsp;Gas (<a href='https://seekingalpha.com/symbol/MCF' title='Contango Oil & Gas Company'>MCF</a> <font color='green'>+6.1%</font>) shoots higher after reporting <a href=\"https://seekingalpha.com/pr/17092244-contango-announces-fourth-quarter-2017-production-year-end-reserves-operations-update-2018\" target=\"_blank\">Q4 production</a> of ~4.8B cfe, or 51.8M cfe/day, which was within guidance despite late December weather  related shut-ins.</li>     <li>MCF says current quarter production was less than the 5.9B cfe, or 64.3M cfe/day,  for the year-ago period due to adding only five new producing  wells to production since the initiation of its Southern Delaware Basin drilling program beginning in late 2016.</li>     <li>MCF says it budgeted $52M to continue developing the Southern Delaware Basin area in 2018 through a one rig program.</li><li>Proved oil and natural gas reserves at year-end 2017 totaled 189.3B cfe vs. 151.8B cfe at the end of 2016.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3336514\" data-linked=\"Contango Oil +6% as Q4 output hits guidance despite weather problems\" data-tweet=\"$MCF - Contango Oil +6% as Q4 output hits guidance despite weather problems https://seekingalpha.com/news/3336514-contango-oilplus-6-q4-output-hits-guidance-despite-weather-problems?source=tweet\" data-url=\"https://seekingalpha.com/news/3336514-contango-oilplus-6-q4-output-hits-guidance-despite-weather-problems\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336511\" data-ts=\"1520280163\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MELI\" target=\"_blank\">MELI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336511-favorable-ruling-on-shipping-fees-for-mercadolibre\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Favorable ruling on shipping fees for MercadoLibre</a></h4><ul> <li>MercadoLibre (<a href='https://seekingalpha.com/symbol/MELI' title='MercadoLibre, Inc.'>MELI</a> <font color='green'>+1%</font>) received some good news when the Brazilian Federal Justice court issued an injunction preventing shipping rate increases from the national post office.</li><li>The decision could be appealed by the Brazilian post office.</li><li>Source: Bloomberg</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3336511\" data-linked=\"Favorable ruling on shipping fees for MercadoLibre\" data-tweet=\"$MELI - Favorable ruling on shipping fees for MercadoLibre https://seekingalpha.com/news/3336511-favorable-ruling-on-shipping-fees-for-mercadolibre?source=tweet\" data-url=\"https://seekingalpha.com/news/3336511-favorable-ruling-on-shipping-fees-for-mercadolibre\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336508\" data-ts=\"1520279729\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NIHD\" target=\"_blank\">NIHD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336508-technology-top-gainers-losers-of-2_55-pm-3-5-18\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 2.55 pm (3/5/18)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/NIHD' title='NII Holdings, Inc.'>NIHD</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/UPLD' title='Upland Software'>UPLD</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/ENPH' title='Enphase Energy Inc.'>ENPH</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/CASA' title='Casa Systems, Inc.'>CASA</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/SQ' title='Square, Inc.'>SQ</a> <font color='green'>+9%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/SPA' title='Sparton Corporation'>SPA</a> <font color='red'>-27%</font>. <a href='https://seekingalpha.com/symbol/SMSI' title='Smith Micro Software, Inc.'>SMSI</a> <font color='red'>-25%</font>. <a href='https://seekingalpha.com/symbol/PAR' title='PAR Technology Corporation'>PAR</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/CRNT' title='Ceragon Networks Ltd.'>CRNT</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/QUMU' title='Qumu Corporation'>QUMU</a> <font color='red'>-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3336508\" data-linked=\"Technology - Top Gainers / Losers as of 2.55 pm (3/5/18)\" data-tweet=\"$NIHD $NIHD $UPLD - Technology - Top Gainers / Losers as of 2.55 pm (3/5/18) https://seekingalpha.com/news/3336508-technology-top-gainers-losers-of-2_55-pm-3-5-18?source=tweet\" data-url=\"https://seekingalpha.com/news/3336508-technology-top-gainers-losers-of-2_55-pm-3-5-18\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336507\" data-ts=\"1520279633\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QCOM\" target=\"_blank\">QCOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336507-bloomberg-qcom-investor-t-rowe-price-voted-for-broadcom-nominees\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bloomberg: QCOM investor T. Rowe Price voted for Broadcom nominees</a></h4><ul><li>           Qualcomm (NASDAQ:<a href='https://seekingalpha.com/symbol/QCOM' title='Qualcomm Inc.'>QCOM</a>) shareholder T. Rowe Price (NASDAQ:<a href='https://seekingalpha.com/symbol/TROW' title='T. Rowe Price Group, Inc.'>TROW</a>) voted for Broadcom&rsquo;s (NASDAQ:<a href='https://seekingalpha.com/symbol/AVGO' title='Broadcom Limited'>AVGO</a>) proposed board nominees, <a href=\"https://www.bloomberg.com/news/articles/2018-03-05/qualcomm-holder-t-rowe-price-said-to-have-voted-broadcom-slate\" target=\"_blank\">according to Bloomberg</a>. </li><li> T. Rowe held a 2.3% stake in Qualcomm last year, making it one of the top 10 shareholders. </li><li> A source says T. Rowe voted for all six of Broadcom&rsquo;s nominees, which would give Broadcom control of its target&rsquo;s board if followed by other investors. </li><li> But the source says T. Rowe&rsquo;s vote could change ahead of the annual meeting that was delayed due to the CFIUS investigation. </li><li> T. Rowe Price shares are&nbsp;<font color='green'>up 1.3%</font>. </li><li> Qualcomm shares are&nbsp;<font color='red'>down 1.3%</font>. </li><li> Broadcom shares are&nbsp;<font color='red'>down 0.8%</font>.&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3336272-cfius-delays-qualcomm-shareholder-meeting\" target=\"_blank\">CFIUS delays Qualcomm shareholder meeting</a> (March 5)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3336372-broadcom-responds-cfius-investigation-delayed-qualcomm-meeting\" target=\"_blank\">Broadcom responds to CFIUS investigation, delayed Qualcomm meeting</a> (March 5)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3336435-qualcomm-says-broadcom-knew-cfius-investigation\" target=\"_blank\">Qualcomm says Broadcom knew about CFIUS investigation</a> (March 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3336507\" data-linked=\"Bloomberg: QCOM investor T. Rowe Price voted for Broadcom nominees\" data-tweet=\"$QCOM $QCOM $TROW - Bloomberg: QCOM investor T. Rowe Price voted for Broadcom nominees https://seekingalpha.com/news/3336507-bloomberg-qcom-investor-t-rowe-price-voted-for-broadcom-nominees?source=tweet\" data-url=\"https://seekingalpha.com/news/3336507-bloomberg-qcom-investor-t-rowe-price-voted-for-broadcom-nominees\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>72&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336505\" data-ts=\"1520278469\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SQ\" target=\"_blank\">SQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336505-square-squeezes-to-new-all-time-high\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Square squeezes to new all-time high</a></h4><ul><li>Other than <a href=\"https://cryptona.co/square-inc-possibly-testing-integration-bitcoin/\" target=\"_blank\">an \"old news\" story </a>about Bitcoin integration, there doesn't appear to anything of note behind Square's (<a href='https://seekingalpha.com/symbol/SQ' title='Square, Inc.'>SQ</a> <font color='green'>+9.4%</font>) jump to a new all-time high today.</li><li>Shares are now<font color='green'> up 45%</font>&nbsp;YTD, and&nbsp;<font color='green'>200%</font>&nbsp;Y/Y.</li></ul><div class=\"tiny-share-widget\" data-id=\"3336505\" data-linked=\"Square squeezes to new all-time high\" data-tweet=\"$SQ - Square squeezes to new all-time high https://seekingalpha.com/news/3336505-square-squeezes-to-new-all-time-high?source=tweet\" data-url=\"https://seekingalpha.com/news/3336505-square-squeezes-to-new-all-time-high\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>67&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336503\" data-ts=\"1520278337\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBUX\" target=\"_blank\">SBUX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336503-lower-rents-give-starbucks-edge-over-dunkin-brands\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lower rents could give Starbucks an edge over Dunkin&#39; Brands</a></h4><ul> <li>Starbucks (<a href='https://seekingalpha.com/symbol/SBUX' title='Starbucks Corporation'>SBUX</a> <font color='green'>+0.5%</font>) may have an advantage over Dunkin Brands (<a href='https://seekingalpha.com/symbol/DNKN' title='Dunkin&#39; Brands'>DNKN</a> <font color='green'>+0.1%</font>) if founder Howard Schultz is correct that <a href=\"https://www.bloomberg.com/news/articles/2018-03-05/starbucks-renting-ways-offer-possible-edge-over-dunkin-donuts\" target=\"_blank\">lower tax payments</a> are on the way.</li> <li>By owning its stores, Starbucks could see higher profit if rent payments come down as opposed to the model at Dunkin' Brands where rents are paid by franchised owners.</li> <li>Shares of Dunkin' Brands are up 10.4% over the last 52 weeks to easily outdistance the 1.8% gain for Starbucks.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3334640-lower-rent-costs-starbucks-u-s\" target=\"_blank\">Lower rent costs for Starbucks in the U.S.?</a> (Feb. 27)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3336503\" data-linked=\"Lower rents could give Starbucks an edge over Dunkin&#39; Brands\" data-tweet=\"$SBUX $SBUX $DNKN - Lower rents could give Starbucks an edge over Dunkin&#39; Brands https://seekingalpha.com/news/3336503-lower-rents-give-starbucks-edge-over-dunkin-brands?source=tweet\" data-url=\"https://seekingalpha.com/news/3336503-lower-rents-give-starbucks-edge-over-dunkin-brands\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336496\" data-ts=\"1520276552\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PAA\" target=\"_blank\">PAA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336496-plains-all-american-ceo-warns-steel-tariff-hurt-pipeline-construction\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Plains All American CEO warns steel tariff could hurt pipeline construction</a></h4><ul><li>Plains All American Pipeline (<a href='https://seekingalpha.com/symbol/PAA' title='Plains All American Pipeline, L.P.'>PAA</a> <font color='green'>+1.7%</font>) CEO Greg Armstrong says Pres. Trump's steel  tariffs could <a href=\"https://www.chron.com/business/energy/article/Plains-All-American-CEO-warns-Trump-steel-tariff-12728838.php\" target=\"_blank\">hurt  pipeline construction in the U.S.</a>, as certain types and sizes of steel pipe, as well as valves and other  equipment, are available only outside the U.S.</li><li>\"We need some flexibility to be able to move forward,\" <a href=\"https://twitter.com/HBJ_Josh/status/970727187212046336\" target=\"_blank\">Armstrong tells</a> the CERAWeek energy conference in Houston. \"If you can't get what you need, you've got to go somewhere else. It's a thornier issue than I think is printed in the headlines.\"</li><li>Armstrong otherwise is bullish on federal actions to date, saying the  permitting and regulatory processes have improved since Trump took  office.</li><li>\"The number of regulations we have to comply with have stacked up over  the years,\" the CEO says. \"The&nbsp;last 12-14 months we've seen a different  attitude, and attitude matters a lot.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3336496\" data-linked=\"Plains All American CEO warns steel tariff could hurt pipeline construction\" data-tweet=\"$PAA - Plains All American CEO warns steel tariff could hurt pipeline construction https://seekingalpha.com/news/3336496-plains-all-american-ceo-warns-steel-tariff-hurt-pipeline-construction?source=tweet\" data-url=\"https://seekingalpha.com/news/3336496-plains-all-american-ceo-warns-steel-tariff-hurt-pipeline-construction\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336495\" data-ts=\"1520276517\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IPI\" target=\"_blank\">IPI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336495-energy-materials-top-gainers-losers-of-2-00-pm-3-5-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm (3/5/2018)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/IPI' title='Intrepid Potash, Inc.'>IPI</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/SAEX' title='SAExploration Holdings, Inc.'>SAEX</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/UAN' title='CVR Partners, LP'>UAN</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/UPL' title='Ultra Petroleum Corp.'>UPL</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/RKDA' title='Arcadia Biosciences'>RKDA</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CEI' title='Camber Energy, Inc.'>CEI</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/LTBR' title='Lightbridge Corp'>LTBR</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/ECR' title='Eclipse Resources'>ECR</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3336495\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm (3/5/2018)\" data-tweet=\"$IPI $IPI $SAEX - Energy/Materials - Top Gainers / Losers as of 2:00 pm (3/5/2018) https://seekingalpha.com/news/3336495-energy-materials-top-gainers-losers-of-2-00-pm-3-5-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3336495-energy-materials-top-gainers-losers-of-2-00-pm-3-5-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336494\" data-ts=\"1520276128\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOX\" target=\"_blank\">FOX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336494-black-panther-run-continues-10th-biggest-u-s-grosser\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">&#39;Black Panther&#39; run continues as 10th biggest U.S. grosser</a></h4><ul>    <li><i>Black Panther's</i> (<a href=\"http://seekingalpha.com/symbol/DIS\" target=\"_blank\">DIS</a> <font color='green'>+0.4%</font>) rampage continues in its third week, stomping to a $65.7M weekend total that puts the superhero film in a historical elite.</li>    <li>It sailed over the $500M mark in domestic grosses -- becoming the third-fastest film ever to hit that level -- and now has a total of $897.7M worldwide.</li>    <li>It also passed 2016's <i>Finding Dory</i> to edge into the top 10 domestic grossers of all time, and likely has a bit of room to run there.</li>    <li>For the weekend, <i>Black Panther</i> topped some nominal opposition from Jennifer Lawrence in <i>Red Sparrow</i> (<a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a> <font color='green'>+1.1%</font>, <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a> <font color='green'>+1.3%</font>) -- which drew $17M and a dedidedly lukewarm-at-best critical reaction -- and Bruce Willis in a remake of <i>Death Wish</i> &#40;MGM&#41;, third-best with $13M.</li>    <li><i>Game Night</i> (<a href=\"http://seekingalpha.com/symbol/TWX\" target=\"_blank\">TWX</a> <font color='green'>+0.8%</font>) and <i>Peter Rabbit</i> (<a href=\"http://seekingalpha.com/symbol/SNE\" target=\"_blank\">SNE</a> <font color='green'>+1.6%</font>) rounded out the top five with $10.7M and $10M respectively.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3336494\" data-linked=\"&#39;Black Panther&#39; run continues as 10th biggest U.S. grosser\" data-tweet=\"$FOX $FOX $FOXA - &#39;Black Panther&#39; run continues as 10th biggest U.S. grosser https://seekingalpha.com/news/3336494-black-panther-run-continues-10th-biggest-u-s-grosser?source=tweet\" data-url=\"https://seekingalpha.com/news/3336494-black-panther-run-continues-10th-biggest-u-s-grosser\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336491\" data-ts=\"1520275059\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TGT\" target=\"_blank\">TGT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336491-target-earnings-preview\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Target earnings preview</a></h4><ul> <li>Target (NYSE:<a href='https://seekingalpha.com/symbol/TGT' title='Target Corporation'>TGT</a>) reports earnings before the opening bell tomorrow and has a financial community meeting scheduled for later in the day.</li> <li>The report from the retailer takes on added significance after Walmart disppointed with its margin outlook last week.</li> <li>Consensus Q4 estimates on Target are for the company to disclose revenue of $22.5B off a 3.4% comp and EPS of $1.38 as a gross margin rate of 26.1% played in. Target's full-year guidance could be the deciding factor on which direction shares move. Last earnings report, Target set initial FY18 guidance for a low single-digit increase in comparable sales and EPS of $5.15 to $5.45. Investors may be disappointed if those numbers aren't bumped up.</li><li>Related: <a href=\"https://seekingalpha.com/article/4152953-tariffs-wages-target-bulls-eye\" target=\"_blank\">Tariffs, Wages And Target In The Bull's-eye</a> (March 3)</li><li>Related: <a href=\"https://seekingalpha.com/article/4153120-target-see-coming-next\" target=\"_blank\">Target: What I See Coming Next</a> (March 5)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3336491\" data-linked=\"Target earnings preview\" data-tweet=\"$TGT - Target earnings preview https://seekingalpha.com/news/3336491-target-earnings-preview?source=tweet\" data-url=\"https://seekingalpha.com/news/3336491-target-earnings-preview\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336481\" data-ts=\"1520273398\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MU\" target=\"_blank\">MU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336481-micron-stoked-baml-report-shares-up-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Micron stoked by BAML report, shares up 6%</a></h4><ul><li>Semiconductor sales were up 23% Y/Y in January, says analyst Vivek Arya, with analog, discrete, and DRAM performing best.</li><li>February is looking a bit slower as inventories get drained off, but things should normalize by the end of Q1. \"We expect broad-based sales improvement for the semi supply chain in Q2,\" says Arya.</li><li>Source: Bloomberg's Lisa Fu</li><li>Micron (NASDAQ:<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology Inc.'>MU</a>) is&nbsp;<font color='green'>higher by 6%</font>, with the SOX&nbsp;<font color='green'>up 1.15%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3336481\" data-linked=\"Micron stoked by BAML report, shares up 6%\" data-tweet=\"$MU - Micron stoked by BAML report, shares up 6% https://seekingalpha.com/news/3336481-micron-stoked-baml-report-shares-up-6?source=tweet\" data-url=\"https://seekingalpha.com/news/3336481-micron-stoked-baml-report-shares-up-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>238&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336475\" data-ts=\"1520272968\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BNTC\" target=\"_blank\">BNTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336475-benitec-launches-mid-stage-study-of-bbminus-401-in-hnscc-shares-up-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Benitec launches mid-stage study of BB-401 in HNSCC; shares up 4%</a></h4><ul><li>Thinly traded nano cap Benitec Biopharma (<a href='https://seekingalpha.com/symbol/BNTC' title='Benitec'>BNTC</a> <font color='green'>+4.2%</font>) <a href=\"https://seekingalpha.com/pr/17091505-benitec-biopharma-launches-phase-2-oncology-study-australia\" target=\"_blank\">commences </a>an Australia and Russia-based <a href=\"https://clinicaltrials.gov/ct2/show/NCT03433027?term=nct03433027&amp;rank=1\" target=\"_blank\">Phase 2 clinical trial</a> evaluating BB-401 in patients with head and neck squamous cell carcinoma &#40;HNSCC&#41;.</li><li>The open-label 30-subject study will assess the safety, tolerability and efficacy of BB-401 administered via intratumoral injection.</li><li>According to ClinicalTrials.gov, the estimated primary completion date is April 2019.</li><li>BB-401 is a recombinant DNA construct that produces an antisense RNA specific to Epidermal Growth Factor Receptor &#40;EGFR&#41;. More than 90% of HNSCC lesions overexpress EGFR. BB-401 is designed to inhibit the expression of EGFR which will control cancer progression.</li></ul><div class=\"tiny-share-widget\" data-id=\"3336475\" data-linked=\"Benitec launches mid-stage study of BB-401 in HNSCC; shares up 4%\" data-tweet=\"$BNTC - Benitec launches mid-stage study of BB-401 in HNSCC; shares up 4% https://seekingalpha.com/news/3336475-benitec-launches-mid-stage-study-of-bbminus-401-in-hnscc-shares-up-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3336475-benitec-launches-mid-stage-study-of-bbminus-401-in-hnscc-shares-up-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336476\" data-ts=\"1520272829\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XL\" target=\"_blank\">XL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336476-financials-top-5-gainers-losers-of-1-00-pm-03-05-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM (03/05/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/XL' title='XL Group plc'>XL</a> <font color='green'>+29%</font>. <a href='https://seekingalpha.com/symbol/CARV' title='Carver Bancorp, Inc.'>CARV</a> <font color='green'>+11%</font>.<a href='https://seekingalpha.com/symbol/GNL' title='Global Net Lease, Inc.'>GNL</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/OCN' title='Ocwen Financial Corporation'>OCN</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/NYMT' title='New York Mortgage Trust, Inc.'>NYMT</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/BKJ' title='Bancorp of New Jersey, Inc.'>BKJ</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3336476\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM (03/05/2018)\" data-tweet=\"$XL $XL $CARV - Financials - Top 5 Gainers / Losers as of 1:00 PM (03/05/2018) https://seekingalpha.com/news/3336476-financials-top-5-gainers-losers-of-1-00-pm-03-05-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3336476-financials-top-5-gainers-losers-of-1-00-pm-03-05-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336467\" data-ts=\"1520272067\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/O\" target=\"_blank\">O</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336467-bargain-hunting-in-reits\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bargain hunting in REITs</a></h4><ul><li>The iShares U.S. Real Estate ETF (<a href='https://seekingalpha.com/symbol/IYR' title='iShares U.S. Real Estate ETF'>IYR</a> <font color='green'>+1.5%</font>) and the Vanguard REIT Index Fund(<a href='https://seekingalpha.com/symbol/VNQ' title='Vanguard Real Estate ETF'>VNQ</a> <font color='green'>+1.5%</font>) have about doubled the S&amp;P 500's advance today.</li><li>Both ETFs remain nearly&nbsp;<font color='red'>10% lower o</font>n the year though.</li><li>Stocks went through a rough patch last week, but it wasn't enough to cool interest rate fears too much. The 10-year Treasury yield remains at 2.88%.</li><li>Equity REIT CEOs, meanwhile, are making their case for buying the dip this week at the <a href=\"https://www.citivelocity.com/mobile/eppublic/resources/events/globalConferenceCalendar.html?supportPiwik=true/\" target=\"_blank\">Citi Global Property Conference</a>.</li><li>Realty Income (<a href='https://seekingalpha.com/symbol/O' title='Realty Income Corporation'>O</a> <font color='green'>+1.7%</font>), Welltower (HCN <font color='green'>+2.2%</font>), Omega Healthcare (<a href='https://seekingalpha.com/symbol/OHI' title='Omega Healthcare Investors, Inc'>OHI</a> <font color='green'>+1.5%</font>), Vereit (<a href='https://seekingalpha.com/symbol/VER' title='VEREIT Inc.'>VER</a> <font color='green'>+2%</font>), Gramercy Property (<a href='https://seekingalpha.com/symbol/GPT' title='Gramercy Property Trust, Inc.'>GPT</a> <font color='green'>+1.7%</font>), Essex Property (<a href='https://seekingalpha.com/symbol/ESS' title='Essex Property Trust, Inc.'>ESS</a> <font color='green'>+1.7%</font>), GGP (GGP <font color='green'>+1.4%</font>), CBL &amp; Associates (<a href='https://seekingalpha.com/symbol/CBL' title='CBL & Associates Properties, Inc.'>CBL</a> <font color='green'>+2.7%</font>), Public Storage (<a href='https://seekingalpha.com/symbol/PSA' title='Public Storage'>PSA</a> <font color='green'>+2%</font>), Boston Properties (<a href='https://seekingalpha.com/symbol/BXP' title='Boston Properties, Inc.'>BXP</a> <font color='green'>+2%</font>), LaSalle Hotel (<a href='https://seekingalpha.com/symbol/LHO' title='LaSalle Hotel Properties'>LHO</a> <font color='green'>+2.5%</font>), Stag Industrial (<a href='https://seekingalpha.com/symbol/STAG' title='STAG Industrial, Inc.'>STAG</a> <font color='green'>+2.2%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3336467\" data-linked=\"Bargain hunting in REITs\" data-tweet=\"$O $IYR $VNQ - Bargain hunting in REITs https://seekingalpha.com/news/3336467-bargain-hunting-in-reits?source=tweet\" data-url=\"https://seekingalpha.com/news/3336467-bargain-hunting-in-reits\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>75&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336466\" data-ts=\"1520272051\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VNDA\" target=\"_blank\">VNDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336466-vandas-hetlioz-shows-potential-to-treat-jet-lag-in-late-stage-study-shares-up-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vanda&#39;s Hetlioz shows potential to treat jet lag in late-stage study; shares up 1%</a></h4><ul><li><a href=\"https://seekingalpha.com/pr/17091326-hetlioz-tasimelteon-demonstrates-efficacy-treat-jet-lag-disorder-8-hour-phase-advance\" target=\"_blank\">Results </a>from a Phase 3 clinical trial, JET8, evaluating Vanda Pharmaceuticals' (<a href='https://seekingalpha.com/symbol/VNDA' title='Vanda Pharmaceuticals Inc.'>VNDA</a> <font color='green'>+1.1%</font>) HETLIOZ (tasimelteon) for the treatment of jet lag disorder showed a treatment effect.</li><li>The study met the primary endpoint of the amount of sleep time in the first 2/3 of the night versus placebo. Specifically, subjects receiving HETLIOZ experienced an 85-minute improvement in total sleep time versus control.</li><li>The company says it will seek regulatory approval for the indication. HETLIOZ is currently approved in the U.S and Europe for the treatment of non-24-hour sleep-wake disorder.</li></ul><div class=\"tiny-share-widget\" data-id=\"3336466\" data-linked=\"Vanda&#39;s Hetlioz shows potential to treat jet lag in late-stage study; shares up 1%\" data-tweet=\"$VNDA - Vanda&#39;s Hetlioz shows potential to treat jet lag in late-stage study; shares up 1% https://seekingalpha.com/news/3336466-vandas-hetlioz-shows-potential-to-treat-jet-lag-in-late-stage-study-shares-up-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3336466-vandas-hetlioz-shows-potential-to-treat-jet-lag-in-late-stage-study-shares-up-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:47 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336465\" data-ts=\"1520271939\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLSD\" target=\"_blank\">CLSD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336465-midday-gainers-losers-3-5-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers (3/5/2018)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CLSD' title='Clearside Biomedical'>CLSD</a> <font color='green'>+36%</font>. <a href='https://seekingalpha.com/symbol/XL' title='XL Group plc'>XL</a> <font color='green'>+29%</font>. <a href='https://seekingalpha.com/symbol/VCEL' title='Vericel Corporation'>VCEL</a> <font color='green'>+28%</font>. <a href='https://seekingalpha.com/symbol/GTXI' title='GTx, Inc.'>GTXI</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/NIHD' title='NII Holdings, Inc.'>NIHD</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/MRNS' title='Marinus Pharmaceuticals'>MRNS</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/CASA' title='Casa Systems, Inc.'>CASA</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/OMEX' title='Odyssey Marine Exploration, Inc.'>OMEX</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/IPI' title='Intrepid Potash, Inc.'>IPI</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/DAVE' title='Famous Dave&#39;s of America, Inc.'>DAVE</a> <font color='green'>+12%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/DERM' title='Dermira'>DERM</a> <font color='red'>-63%</font>. <a href='https://seekingalpha.com/symbol/SPA' title='Sparton Corporation'>SPA</a> <font color='red'>-26%</font>. <a href='https://seekingalpha.com/symbol/SMSI' title='Smith Micro Software, Inc.'>SMSI</a> <font color='red'>-26%</font>. <a href='https://seekingalpha.com/symbol/CEI' title='Camber Energy, Inc.'>CEI</a> <font color='red'>-23%</font>. <a href='https://seekingalpha.com/symbol/BRFS' title='BRF-Brasil Foods S.A.'>BRFS</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/VEC' title='Vectrus'>VEC</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/USAK' title='USA Truck, Inc.'>USAK</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/AEZS' title='AEterna Zentaris, Inc.'>AEZS</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/ENT' title='Global Eagle Entertainment, Inc.'>ENT</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/LTBR' title='Lightbridge Corp'>LTBR</a> <font color='red'>-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3336465\" data-linked=\"Midday Gainers / Losers (3/5/2018)\" data-tweet=\"$CLSD $CLSD $XL - Midday Gainers / Losers (3/5/2018) https://seekingalpha.com/news/3336465-midday-gainers-losers-3-5-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3336465-midday-gainers-losers-3-5-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336464\" data-ts=\"1520271304\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RCAR\" target=\"_blank\">RCAR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336464-renovacare-files-complaint-against-short-sellers-shares-down-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RenovaCare files complaint against short sellers; shares down 4%</a></h4><ul><li>Thinly traded micro cap RenovaCare (<a href='https://seekingalpha.com/symbol/RCAR' title='RenovaCare, Inc.'>OTCPK:RCAR</a> <font color='red'>-4.2%</font>) says it is filing a <a href=\"https://seekingalpha.com/pr/17091634-renovacare-takes-action-protect-shareholder-interests\" target=\"_blank\">formal complaint</a> with FINRA and the SEC against what it calls \"predatory trading practices\" by several unnamed FINRA member firms who are allegedly making false statements to depress shares, adding that it has video evidence of said behavior.</li><li>Management states that no officers or directors have sold shares and top investor Kalen Capital has not sold any shares since 2008.</li><li>Shares were down almost&nbsp;<font color='red'>14%</font>&nbsp;before recovering.</li></ul><div class=\"tiny-share-widget\" data-id=\"3336464\" data-linked=\"RenovaCare files complaint against short sellers; shares down 4%\" data-tweet=\"$RCAR - RenovaCare files complaint against short sellers; shares down 4% https://seekingalpha.com/news/3336464-renovacare-files-complaint-against-short-sellers-shares-down-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3336464-renovacare-files-complaint-against-short-sellers-shares-down-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336461\" data-ts=\"1520270994\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COUP\" target=\"_blank\">COUP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336461-coupa-software-hits-new-high-after-price-target-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Coupa Software hits new high after price target upgrade</a></h4><ul><li>        Barclays maintains an Overweight rating and raises its Coupa Software (NASDAQ:<a href='https://seekingalpha.com/symbol/COUP' title='Coupa Software Inc'>COUP</a>) price target from $38 to $47.</li><li>               Firm sees the company&rsquo;s story coming together a year after the IPO with increasing spend, high-profile customers, and brand awareness.&nbsp;</li><li>               Barclays expects Coupa&rsquo;s momentum to continue into the Q4 report with an outperformance.&nbsp;</li><li>               But Barclays says Coupa is a top-performer, up 46% YTD compared to the 1% growth of the S&amp;P, and that could temper share reaction. &nbsp;&nbsp;</li><li>               Source:Briefing.com.&nbsp;</li><li>               Coupa shares are&nbsp;<font color='green'>up 1.9%</font>&nbsp;to $46.42 and hit a new 52-week high earlier at $47.12.&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3336461\" data-linked=\"Coupa Software hits new high after price target upgrade\" data-tweet=\"$COUP - Coupa Software hits new high after price target upgrade https://seekingalpha.com/news/3336461-coupa-software-hits-new-high-after-price-target-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3336461-coupa-software-hits-new-high-after-price-target-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:29 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336458\" data-ts=\"1520270602\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JD\" target=\"_blank\">JD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336458-jd-comminus-2_2-sws-cuts-to-outperform\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JD.com -2.2% as SWS cuts to Outperform</a></h4><ul>   <li>JD.com (NASDAQ:<a href='https://seekingalpha.com/symbol/JD' title='JD.com'>JD</a>) is <font color='red'>2.2% lower</font> today, and tracking toward its third straight down trading day, after a downgrade of its ADRs to Outperform by SWS.</li>    <li>The firm did update its price target higher, to $50 from $47, implying 17% upside.</li>    <li>Declines have brought its YTD gains down to 3.3%, though the ADRs are <font color='green'>up 14.8%</font> over the past three months.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3336458\" data-linked=\"JD.com -2.2% as SWS cuts to Outperform\" data-tweet=\"$JD - JD.com -2.2% as SWS cuts to Outperform https://seekingalpha.com/news/3336458-jd-comminus-2_2-sws-cuts-to-outperform?source=tweet\" data-url=\"https://seekingalpha.com/news/3336458-jd-comminus-2_2-sws-cuts-to-outperform\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336452\" data-ts=\"1520269822\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TCLRY\" target=\"_blank\">TCLRY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336452-technicolor-names-publicis-carozzi-chief-financial-officer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technicolor names Publicis&#39; Carozzi its chief financial officer</a></h4><ul>   <li>Technicolor (<a href=\"http://seekingalpha.com/symbol/TCLRY\" target=\"_blank\">TCLRY</a> <font color='red'>-2.8%</font>) has tapped Laurent Carozzi, deputy CFO at Publicis (<a href=\"http://seekingalpha.com/symbol/PUBGY\" target=\"_blank\">PUBGY</a> <font color='red'>-0.3%</font>), to be its <a href=\"https://seekingalpha.com/pr/17092129-technicolor-technicolor-appoints-laurent-carozzi-chief-financial-officer\" target=\"_blank\">new chief financial officer</a>.</li>    <li>Carozzi will be a member of the executive committee effective next Monday.</li>    <li>Prior to Publicis, he spent 12 years with Lagardere Group. He started his career in the banking industry in 1989.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3336452\" data-linked=\"Technicolor names Publicis&#39; Carozzi its chief financial officer\" data-tweet=\"$TCLRY $TCLRY $PUBGY - Technicolor names Publicis&#39; Carozzi its chief financial officer https://seekingalpha.com/news/3336452-technicolor-names-publicis-carozzi-chief-financial-officer?source=tweet\" data-url=\"https://seekingalpha.com/news/3336452-technicolor-names-publicis-carozzi-chief-financial-officer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336450\" data-ts=\"1520269334\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RCKY\" target=\"_blank\">RCKY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336450-consumer-top-gainers-losers-of-12-00-pm-3-5-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm (3/5/2018)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/RCKY' title='Rocky Brands, Inc.'>RCKY</a> <font color='green'>+8%</font>. AOI <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/SUMR' title='Summer Infant, Inc.'>SUMR</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/NBEV' title='New Age Beverages Corporation'>NBEV</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/NAKD' title='Naked Brand Group Limited'>NAKD</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/BRFS' title='BRF-Brasil Foods S.A.'>BRFS</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/ESND' title='Essendant'>ESND</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/CELH' title='Celsius Holdings, Inc.'>CELH</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/JAKK' title='JAKKS Pacific, Inc.'>JAKK</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3336450\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm (3/5/2018)\" data-tweet=\"$RCKY $RCKY $PYX - Consumer - Top Gainers / Losers as of 12:00 pm (3/5/2018) https://seekingalpha.com/news/3336450-consumer-top-gainers-losers-of-12-00-pm-3-5-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3336450-consumer-top-gainers-losers-of-12-00-pm-3-5-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336447\" data-ts=\"1520269136\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HLIT\" target=\"_blank\">HLIT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336447-harmonic-earns-win-indias-tv-today-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Harmonic earns win with India&#39;s TV Today news</a></h4><ul>    <li>Harmonic (<a href=\"http://seekingalpha.com/symbol/HLIT\" target=\"_blank\">HLIT</a> <font color='green'>+5.8%</font>) notes its contribution &amp; distribution solution has been <a href=\"https://seekingalpha.com/pr/17091473-indias-tv-today-network-chooses-harmonic-ultra-low-latency-contribution-solution\" target=\"_blank\">chosen by TV Today</a>, a leaing breaking news channel in India.</li>    <li>The network says that since deploying Harmonic's low-latency solution, \"we've opened up a significant amount of additional usable satellite bandwidth while maintaining superior video quality.\"</li>    <li>India is driving pay TV broadcast growth in Asia Pacific with 65% of regional revenue, Harmonic notes; the company is set to present its latest video delivery work at Convergence India in New Delhi later this week.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3336447\" data-linked=\"Harmonic earns win with India&#39;s TV Today news\" data-tweet=\"$HLIT - Harmonic earns win with India&#39;s TV Today news https://seekingalpha.com/news/3336447-harmonic-earns-win-indias-tv-today-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3336447-harmonic-earns-win-indias-tv-today-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336437\" data-ts=\"1520267575\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEUM\" target=\"_blank\">TEUM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336437-pareteum-platform-wins-iot-evolution-award\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pareteum platform wins IoT Evolution award</a></h4><ul>   <li>Pareteum (<a href=\"http://seekingalpha.com/symbol/TEUM\" target=\"_blank\">TEUM</a> <font color='green'>+4.9%</font>) says its Global Cloud has won IoT Evolution's <a href=\"https://seekingalpha.com/pr/17091487-pareteum-global-cloud-wins-iot-evolutions-2017-iot-excellence-award\" target=\"_blank\">2017 IoT Excellence Award</a>, an honor named by TMC and Crossfire Media.</li>    <li>IoT has a potential economic impact of $3.9T-$11.1T per year by 2025, Pareteum says, pointing to McKinsey data. The company's well positioned to capture more of that market, says Chairman Hal Turner.</li>    <li>Shares in the company are <font color='green'>up 12.6%</font> YTD and have <font color='green'>risen 174%</font> over the past three months.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3336437\" data-linked=\"Pareteum platform wins IoT Evolution award\" data-tweet=\"$TEUM - Pareteum platform wins IoT Evolution award https://seekingalpha.com/news/3336437-pareteum-platform-wins-iot-evolution-award?source=tweet\" data-url=\"https://seekingalpha.com/news/3336437-pareteum-platform-wins-iot-evolution-award\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336435\" data-ts=\"1520267412\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QCOM\" target=\"_blank\">QCOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336435-qualcomm-says-broadcom-knew-cfius-investigation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Qualcomm says Broadcom knew about CFIUS investigation</a></h4><ul><li>        Qualcomm (NASDAQ:<a href='https://seekingalpha.com/symbol/QCOM' title='Qualcomm Inc.'>QCOM</a>) <a href=\"https://seekingalpha.com/pr/17092070-qualcomm-responds-broadcom-statement\" target=\"_blank\">fires back</a> at Broadcom&rsquo;s (NASDAQ:<a href='https://seekingalpha.com/symbol/AVGO' title='Broadcom Limited'>AVGO</a>) claim that it was surprised by the CFIUS investigation.</li><li>               Qualcomm says Broadcom has interacted with CFIUS for weeks, including two written submissions.&nbsp;</li><li>               Key quote: &ldquo;Broadcom Limited's response to the order from the Committee on Foreign Investment in the&nbsp;U.S. &#40;CFIUS&#41; is a continuation of its now familiar pattern of deliberately seeking to mislead shareholders and the general public by using rhetoric rather than substance to trivialize and ignore serious regulatory and national security issues&hellip; Broadcom's dismissive rhetoric notwithstanding, this is a very serious matter for both Qualcomm and Broadcom.&rdquo;&nbsp;</li><li>               Qualcomm shares are&nbsp;<font color='red'>down 0.6%</font>&nbsp;to $64.34.&nbsp;&nbsp;</li><li>               Broadcom shares are&nbsp;<font color='red'>down 0.6%</font>&nbsp;to $249.38.&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3336272-cfius-delays-qualcomm-shareholder-meeting\" target=\"_blank\">CFIUS delays Qualcomm shareholder meeting</a> (March 5)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3336372-broadcom-responds-cfius-investigation-delayed-qualcomm-meeting\" target=\"_blank\">Broadcom responds to CFIUS investigation, delayed Qualcomm meeting</a> (March 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3336435\" data-linked=\"Qualcomm says Broadcom knew about CFIUS investigation\" data-tweet=\"$QCOM $QCOM $AVGO - Qualcomm says Broadcom knew about CFIUS investigation https://seekingalpha.com/news/3336435-qualcomm-says-broadcom-knew-cfius-investigation?source=tweet\" data-url=\"https://seekingalpha.com/news/3336435-qualcomm-says-broadcom-knew-cfius-investigation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>57&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336433\" data-ts=\"1520267129\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XSPA\" target=\"_blank\">XSPA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336433-xpresspa-names-bernstein-chairman-of-board\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">XpresSpa names Bernstein chairman of the board</a></h4><ul>   <li>XpresSpa (<a href=\"http://seekingalpha.com/symbol/XSPA\" target=\"_blank\">XSPA</a> <font color='green'>+4.4%</font>) has named Bruce Bernstein its <a href=\"https://seekingalpha.com/pr/17091539-xpresspa-group-board-directors-elects-chairman\" target=\"_blank\">chairman of the board</a>.</li>    <li>Bernstein has been an independent director on the audit and compensation committees, a member of the board since February 2016.</li>    <li>He takes over the board as the company refocuses on health and wellness and looks to shed noncore assets. His experience spans start-ups and public companies, the firm notes, across domains of finance, deal structure, supply chain and branding.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3336433\" data-linked=\"XpresSpa names Bernstein chairman of the board\" data-tweet=\"$XSPA - XpresSpa names Bernstein chairman of the board https://seekingalpha.com/news/3336433-xpresspa-names-bernstein-chairman-of-board?source=tweet\" data-url=\"https://seekingalpha.com/news/3336433-xpresspa-names-bernstein-chairman-of-board\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336436\" data-ts=\"1520266715\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMTL\" target=\"_blank\">CMTL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336436-comtech-bags-contract-worth-123_6m-from-u-s-army\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Comtech bags contract worth  $123.6M from U.S. Army</a></h4><ul>     <li>Comtech Telecommunications (<a href='https://seekingalpha.com/symbol/CMTL' title='Comtech Telecommunications Corp.'>CMTL</a> <font color='green'>+1.4%</font>) announced that its Government Solutions segment, during Q218,&nbsp; has received a 3 year contract valued at ~$123.6M.</li>     <li>The contract is to provide ongoing sustainment services for the AN/TSC-198A SNAP and Non-classified Internet Protocol Router &amp; VSAT.</li>     <li>The contract was initially funded at $3.1M with additional funding expected to occur across the performance period.</li><li><a href=\"https://seekingalpha.com/pr/17091924-comtech-awarded-three-year-123_6-million-contract-u-s-army\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3336436\" data-linked=\"Comtech bags contract worth  $123.6M from U.S. Army\" data-tweet=\"$CMTL - Comtech bags contract worth $123.6M from U.S. Army https://seekingalpha.com/news/3336436-comtech-bags-contract-worth-123_6m-from-u-s-army?source=tweet\" data-url=\"https://seekingalpha.com/news/3336436-comtech-bags-contract-worth-123_6m-from-u-s-army\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336429\" data-ts=\"1520266261\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336429-brexit-deal-comments-send-pound-higher-u-k-stocks-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Brexit deal comments send pound higher, U.K. stocks lower</a></h4><ul><li>\"I am confident we can resolve our remaining differences in the days ahead,\" says U.K. Prime Minister Theresa May, addressing Parliament a short while ago.</li><li>The \"differences\" she's referring to are with the European Union over Brexit. \"We are close to an agreement,\" says May.</li><li>Speaking later, Labour's Jeremy Corbyn says the government is \"nowhere near\" a deal.</li><li>The pound (NYSEARCA:<a href='https://seekingalpha.com/symbol/FXB' title='CurrencyShares British Pound Sterling Trust ETF'>FXB</a>) is nevertheless on the move,&nbsp;<font color='green'>up 0.4%</font>&nbsp;vs. the dollar at $1.3852. The FTSE 100 (NYSEARCA:<a href='https://seekingalpha.com/symbol/EWU' title='iShares MSCI United Kingdom ETF'>EWU</a>) has slipped from earlier levels, now&nbsp;<font color='green'>up just 0.25%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3336429\" data-linked=\"Brexit deal comments send pound higher, U.K. stocks lower\" data-tweet=\"$FXB $EWU - Brexit deal comments send pound higher, U.K. stocks lower https://seekingalpha.com/news/3336429-brexit-deal-comments-send-pound-higher-u-k-stocks-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/3336429-brexit-deal-comments-send-pound-higher-u-k-stocks-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336428\" data-ts=\"1520266260\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BG\" target=\"_blank\">BG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336428-bungeplus-4-investors-reportedly-pressure-to-consider-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bunge +4% as investors reportedly pressure it to consider sale</a></h4><ul>     <li>Bunge (<a href='https://seekingalpha.com/symbol/BG' title='Bunge Limited'>BG</a> <font color='green'>+4.3%</font>) moves higher following a <em>WSJ</em> report that investor Continental Grain is pressuring the company to <a href=\"https://www.wsj.com/articles/investor-continental-grain-is-set-to-pressure-bunge-to-sell-itself-1520266146\" target=\"_blank\">consider selling itself</a>.</li>     <li>Continental Grain, which owns more than 1% of Bunge, is expected to secure approval from U.S. antitrust regulators to purchase more stock, according to the report.</li>     <li>Also, Archer Daniels Midland (<a href='https://seekingalpha.com/symbol/ADM' title='Archer Daniels Midland Co.'>ADM</a> <font color='green'>+0.5%</font>) is looking to thwart Glencore&rsquo;s (<a href='https://seekingalpha.com/symbol/GLCNF' title='Glencore Plc'>OTCPK:GLCNF</a>, <a href='https://seekingalpha.com/symbol/GLNCY' title='Glencore Plc ADR'>OTCPK:GLNCY</a>) pursuit of Bunge by <a href=\"https://www.thetimes.co.uk/article/us-food-giant-archer-daniels-midland-looks-to-asian-partner-to-thwart-glencore-in-race-for-bunge-r3js3zljj\" target=\"_blank\">teaming up with a mystery Asian company</a>, according to a report from London's <em>Sunday Times</em>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3336428\" data-linked=\"Bunge +4% as investors reportedly pressure it to consider sale\" data-tweet=\"$BG $BG $ADM - Bunge +4% as investors reportedly pressure it to consider sale https://seekingalpha.com/news/3336428-bungeplus-4-investors-reportedly-pressure-to-consider-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3336428-bungeplus-4-investors-reportedly-pressure-to-consider-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336427\" data-ts=\"1520266193\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WIZP\" target=\"_blank\">WIZP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336427-wize-pharma-reverse-splits-shares-1-24-effective-today\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wize Pharma reverse splits shares 1:24 effective today</a></h4><ul><li>Aimed at boosting visibility and interest from more investors, Wize Pharma (<a href='https://seekingalpha.com/symbol/WIZP' title='Wize Pharma, Inc.'>OTCQB:WIZP</a>) has <a href=\"https://seekingalpha.com/pr/17091877-wize-pharma-announces-reverse-stock-split-effective-march-5-2018\" target=\"_blank\">executed </a>a 1:24 reverse split of its common stock effective at the open today.</li></ul><div class=\"tiny-share-widget\" data-id=\"3336427\" data-linked=\"Wize Pharma reverse splits shares 1:24 effective today\" data-tweet=\"$WIZP - Wize Pharma reverse splits shares 1:24 effective today https://seekingalpha.com/news/3336427-wize-pharma-reverse-splits-shares-1-24-effective-today?source=tweet\" data-url=\"https://seekingalpha.com/news/3336427-wize-pharma-reverse-splits-shares-1-24-effective-today\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336425\" data-ts=\"1520266073\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LYFT\" target=\"_blank\">LYFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336425-lyft-and-allscripts-partner-on-health-care-transportation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lyft and Allscripts partner on health care transportation</a></h4><ul><li>        Lyft (<a href='https://seekingalpha.com/symbol/LYFT' title='Lyft'>LYFT</a>) <a href=\"https://techcrunch.com/2018/03/05/lyft-commits-to-cutting-the-problem-of-health-care-transportation-in-half-by-2020/?ncid=rss&amp;utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+Techcrunch+%28TechCrunch%29\" target=\"_blank\">adds</a> Allscripts (NASDAQ:<a href='https://seekingalpha.com/symbol/MDRX' title='Allscripts Healthcare Solutions, Inc.'>MDRX</a>) to its list of platform partners for health care transportation.</li><li>               Lyft will provide Allscripts with API access to integrate the ride-hailing system into the Allscripts open health platform and electronic health records services.&nbsp;</li><li>               The electronic health records integration will help automatically detect any special transportation needs in a patient&rsquo;s medical file.&nbsp;</li><li>               Other partners include Blue Cross Blue Shield and Ascension.&nbsp;</li><li>               Lack of medical transportation to non-emergency visits keeps millions of Americans out of the doctor&rsquo;s office. Lyft wants to halve that number by 2020.&nbsp;&nbsp;</li><li>               Last week, Uber (<a href='https://seekingalpha.com/symbol/UBER' title='Uber'>UBER</a>) launched the Uber Health tool for rides to appointments. Both Uber and Lyft have relationships with Circulation, a digital platform provider for health care transportation.&nbsp;</li><li>                  Allscripts shares are&nbsp;<font color='red'>down 0.2%</font>&nbsp;to $14.14.&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3335702-brazil-votes-ubers-favor-uber-health-tool-launches-doc-appointments\" target=\"_blank\">Brazil votes in Uber's favor; Uber Health tool launches for doc appointments</a> (March 1)</li></ul><div class=\"tiny-share-widget\" data-id=\"3336425\" data-linked=\"Lyft and Allscripts partner on health care transportation\" data-tweet=\"$LYFT $LYFT $MDRX - Lyft and Allscripts partner on health care transportation https://seekingalpha.com/news/3336425-lyft-and-allscripts-partner-on-health-care-transportation?source=tweet\" data-url=\"https://seekingalpha.com/news/3336425-lyft-and-allscripts-partner-on-health-care-transportation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:07 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336424\" data-ts=\"1520265753\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/USAK\" target=\"_blank\">USAK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336424-trucking-stocks-trade-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trucking stocks trade lower</a></h4><ul> <li>The trucking sector is showing some weakness today, presumably due to investor concerns over how changes with trade, tariffs and NAFTA could impact the sector.</li> <li>Notable decliners include USA Truck (<a href='https://seekingalpha.com/symbol/USAK' title='USA Truck, Inc.'>USAK</a> <font color='red'>-12.9%</font>), Convenant Transportation (<a href='https://seekingalpha.com/symbol/CVTI' title='Covenant Transportation Group, Inc.'>CVTI</a> <font color='red'>-3.7%</font>), Echo Global Logistics (<a href='https://seekingalpha.com/symbol/ECHO' title='Echo Global Logistics, Inc.'>ECHO</a> <font color='red'>-2.8%</font>), YRC Worldwide (<a href='https://seekingalpha.com/symbol/YRCW' title='YRC Worldwide, Inc.'>YRCW</a> <font color='red'>-1.8%</font>), ArcBest (<a href='https://seekingalpha.com/symbol/ARCB' title='ArcBest Corporation'>ARCB</a> <font color='red'>-2.1%</font>), J.B. Hunt Transport Services (<a href='https://seekingalpha.com/symbol/JBHT' title='J.B. Hunt Transport Services, Inc.'>JBHT</a> <font color='red'>-2.4%</font>), Werner Enterprises (<a href='https://seekingalpha.com/symbol/WERN' title='Werner Enterprises, Inc.'>WERN</a> <font color='red'>-1.7%</font>), Heartland Express (<a href='https://seekingalpha.com/symbol/HTLD' title='Heartland Express, Inc.'>HTLD</a> <font color='red'>-1.9%</font>) and Old Dominion Freight Line (<a href='https://seekingalpha.com/symbol/ODFL' title='Old Dominion Freight Line, Inc.'>ODFL</a> <font color='red'>-1.4%</font>).</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3336424\" data-linked=\"Trucking stocks trade lower\" data-tweet=\"$USAK $USAK $CVTI - Trucking stocks trade lower https://seekingalpha.com/news/3336424-trucking-stocks-trade-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/3336424-trucking-stocks-trade-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336402\" data-ts=\"1520265704\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLSD\" target=\"_blank\">CLSD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336402-healthcare-gainers-losers-of-11-00-3-5-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare Gainers / Losers as of 11:00 am (3/5/2018)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CLSD' title='Clearside Biomedical'>CLSD</a> <font color='green'>+39%</font>. <a href='https://seekingalpha.com/symbol/VCEL' title='Vericel Corporation'>VCEL</a> <font color='green'>+28%</font>. <a href='https://seekingalpha.com/symbol/GTXI' title='GTx, Inc.'>GTXI</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/AVGR' title='Avinger'>AVGR</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/INFI' title='Infinity Pharmaceuticals, Inc.'>INFI</a> <font color='green'>+14%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/DERM' title='Dermira'>DERM</a> <font color='red'>-63%</font>. <a href='https://seekingalpha.com/symbol/AEZS' title='AEterna Zentaris, Inc.'>AEZS</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/HTBX' title='Heat Biologics, Inc.'>HTBX</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/NBY' title='NovaBay Pharmaceuticals, Inc.'>NBY</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/REPH' title='Recro Pharma Inc'>REPH</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3336402\" data-linked=\"Healthcare Gainers / Losers as of 11:00 am (3/5/2018)\" data-tweet=\"$CLSD $CLSD $VCEL - Healthcare Gainers / Losers as of 11:00 am (3/5/2018) https://seekingalpha.com/news/3336402-healthcare-gainers-losers-of-11-00-3-5-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3336402-healthcare-gainers-losers-of-11-00-3-5-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336419\" data-ts=\"1520265568\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GE\" target=\"_blank\">GE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336419-ge-shares-rally-following-positive-blair-note-targeting-20-22\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GE shares rally following positive Blair note targeting $20-$22</a></h4><ul>     <li>Shares of General Electric (<a href='https://seekingalpha.com/symbol/GE' title='General Electric'>GE</a> <font color='green'>+2.8%</font>) <a href=\"https://thefly.com/thestreet/realmoney/index.php/GEid2693934/GE-William-Blair-sees-GE-shares-stabilizing-then-heading-to-\" target=\"_blank\">should begin to stabilize</a> following <a href=\"https://seekingalpha.com/news/3334053-ge-nominates-three-new-board-directors\" target=\"_blank\">last week's announcement</a> of three \"highly capable\" new directors, and the company's year-end financials did not include any new material disclosures likely to adversely affect its future fundamental performance, says William Blair analyst Nicholas Heymann, rating the stock at Outperform.</li>     <li>The analyst lists five reasons why GE shares are likely to offer upside potential over the near and intermediate term: oil  prices nearing three-year highs, the CEO's belief that shareholder and bondholder lawsuits could be resolved without material adverse financial impact, the performance of GE's aviation and healthcare businesses, improving cash generation, and the company being well positioned to \"materially reduce\" its underfunded pension plan in 2018.</li>     <li>GE's focus on better than expected free cash flow and accelerated pace of asset sales likely will enable the shares to return to a \"normalized\" valuation of 20x trough 2018 adjusted EPS of $1.00-$1.07, or a valuation in the $20-$22 range, Heymann says.</li></ul><div class=\"tiny-share-widget\" data-id=\"3336419\" data-linked=\"GE shares rally following positive Blair note targeting $20-$22\" data-tweet=\"$GE - GE shares rally following positive Blair note targeting $20-$22 https://seekingalpha.com/news/3336419-ge-shares-rally-following-positive-blair-note-targeting-20-22?source=tweet\" data-url=\"https://seekingalpha.com/news/3336419-ge-shares-rally-following-positive-blair-note-targeting-20-22\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>93&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336418\" data-ts=\"1520265532\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOX\" target=\"_blank\">FOX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336418-oscars-ratings-down-16-may-plumb-all-time-low-updated\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oscars ratings down 16%, may plumb all-time low (updated)</a></h4><ul>    <li>The Oscars telecast provided a now-to-be-expected ratings decline for ABC (<a href=\"http://seekingalpha.com/symbol/DIS\" target=\"_blank\">DIS</a> <font color='green'>+0.1%</font>), with overnight ratings suggesting the show may have hit an all-time low in viewership.</li>    <li>Early numbers suggest an 18.9 overnight rating from 8-11 p.m. ET, <a href=\"www.hollywoodreporter.com/live-feed/tv-ratings-oscars-eye-new-low-early-numbers-1091636\" target=\"_blank\">down 16% Y/Y</a>. Last year's Oscars earned a 22.4 and drew 32.9M viewers, second-lowest total ever (though today's overnights don't yet reflect the end of the show with the biggest awards).</li>    <li>On the advertiser side, ABC had marked its <a href=\"https://seekingalpha.com/news/3333623-oscars-broadcast-marks-abcs-fastest-ever-ad-spot-sellout\" target=\"_blank\">earliest sellout of spots ever</a> and was looking for up to $2.6M for a 30-second spot on the broadcast.</li>    <li>The 2008 show's 31.8M viewers drew the lowest viewership. Full numbers come from Nielsen later on.</li>    <li>While the Oscar is more of a prestige win, success at the industry's top awards show can mean some boost for winning studios' top lines. The top-winning studio was Fox Searchlight (<a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a> <font color='green'>+0.1%</font>, <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a> <font color='green'>+0.3%</font>) with six wins, followed by Warner Bros. (<a href=\"http://seekingalpha.com/symbol/TWX\" target=\"_blank\">TWX</a> <font color='green'>+0.7%</font>) with five. Focus Features (<a href=\"http://seekingalpha.com/symbol/CMCSA\" target=\"_blank\">CMCSA</a> <font color='red'>-0.1%</font>) took three Oscars, while Disney (NYSE:<a href='https://seekingalpha.com/symbol/DIS' title='The Walt Disney Company'>DIS</a>) had two, and Sony (<a href=\"http://seekingalpha.com/symbol/SNE\" target=\"_blank\">SNE</a> <font color='green'>+0.8%</font>) had two while its Sony Pictures Classics label took two more.</li>    <li>Meanwhile, after making some prestige inroads in the past, Netflix (<a href=\"http://seekingalpha.com/symbol/NFLX\" target=\"_blank\">NFLX</a> <font color='green'>+2.3%</font>) ended up with just one award.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3336260-shape-water-wins-best-picture-oscar\" target=\"_blank\">'Shape of Water' wins Best Picture Oscar</a> (Mar. 05 2018)</li><li><strong>Updated 3:41 p.m.:&nbsp;</strong>The 2018 telecast was indeed the least watched ever, with 26.5M&nbsp;viewers, down 19% and more than 5M&nbsp;viewers lighter than the 2008 telecast.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3336418\" data-linked=\"Oscars ratings down 16%, may plumb all-time low (updated)\" data-tweet=\"$FOX $FOX $FOXA - Oscars ratings down 16%, may plumb all-time low (updated) https://seekingalpha.com/news/3336418-oscars-ratings-down-16-may-plumb-all-time-low-updated?source=tweet\" data-url=\"https://seekingalpha.com/news/3336418-oscars-ratings-down-16-may-plumb-all-time-low-updated\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>101&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336413\" data-ts=\"1520264428\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZICX\" target=\"_blank\">ZICX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336413-zicix-to-acquire-marketing-digest\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zicix to acquire Marketing Digest</a></h4><ul> <li>Zicix (<a href='https://seekingalpha.com/symbol/ZICX' title='Zicix Corporation'>OTCPK:ZICX</a>) to acquire Marketing Digest, a privately held company located in Springfield, NJ.</li>       <li>In making today&rsquo;s announcement, Zicix President, William Petty said, &ldquo;I am pleased to announce that test marketing will be underway within a few weeks and that Zicix Corporation will be able to announce an innovative mobile application designed to increase the consumer&rsquo;s maximum value in obtaining and using digital coupons.&rdquo;</li>  <li><a href=\"https://seekingalpha.com/pr/17091965-zicix-corporation-acquire-marketing-digest-inc\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3336413\" data-linked=\"Zicix to acquire Marketing Digest\" data-tweet=\"$ZICX - Zicix to acquire Marketing Digest https://seekingalpha.com/news/3336413-zicix-to-acquire-marketing-digest?source=tweet\" data-url=\"https://seekingalpha.com/news/3336413-zicix-to-acquire-marketing-digest\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:40 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336411\" data-ts=\"1520264332\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DLGNF\" target=\"_blank\">DLGNF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336411-dialog-semiconductor-says-apple-contract-stretches-2020\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dialog Semiconductor says Apple contract stretches into 2020</a></h4><ul><li>        Dialog Semiconductor (<a href='https://seekingalpha.com/symbol/DLGNF' title='Dialog Semiconductor Plc'>OTCPK:DLGNF</a>) shares&nbsp;<font color='green'>gain 2.2%</font>&nbsp;on Saturday&rsquo;s report that the company has a contract to <a href=\"https://www.reuters.com/article/us-apple-power-chip-dialog-outlook/dialog-expects-to-supply-chips-to-apple-through-2020-ceo-in-paper-idUSKCN1GF0BN?feedType=RSS&amp;feedName=technologyNews&amp;utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+reuters%2FtechnologyNews+%28Reuters+Technology+News%29\" target=\"_blank\">provide Apple chips into 2020</a>.</li><li>               Last year, the company warned that its time as a power management chip supplier to Apple was coming to an end as the tech giant worked to develop its own chips.&nbsp;</li><li>               Dialog&rsquo;s 2018 contracts were safe and the company said it was already working on its products for next year, suggesting a 2020 cutoff date.&nbsp;</li><li>               But CEO Jalal Bagherli tells a German newspaper that the contract lasts a bit longer.&nbsp;</li><li>               Analysts think Dialog brings in about half of its revenue from Apple.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3315381-nikkei-apple-will-design-main-power-management-chips-iphones-update\" target=\"_blank\">Nikkei: Apple will design main power management chips for iPhones (update)</a> (Nov. 30, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3336411\" data-linked=\"Dialog Semiconductor says Apple contract stretches into 2020\" data-tweet=\"$DLGNF - Dialog Semiconductor says Apple contract stretches into 2020 https://seekingalpha.com/news/3336411-dialog-semiconductor-says-apple-contract-stretches-2020?source=tweet\" data-url=\"https://seekingalpha.com/news/3336411-dialog-semiconductor-says-apple-contract-stretches-2020\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336408\" data-ts=\"1520263355\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MD\" target=\"_blank\">MD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336408-mednax-slips-3-on-short-call-off-wall-street\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mednax slips 3% on short call by Off Wall Street</a></h4><ul><li>MEDNAX (<a href='https://seekingalpha.com/symbol/MD' title='Mednax, Inc.'>MD</a> <font color='red'>-3%</font>) is under modest pressure in apparent response to a bearish <a href=\"https://www.streetinsider.com/Analyst+Comments/MEDNAX+%28MD%29+Initiated+as+Short+at+Off+Wall+Street/13901426.html\" target=\"_blank\">report </a>by Off Wall Street. It rates the stock a Sell with a $38.41 (28% downside risk) price target.</li></ul><div class=\"tiny-share-widget\" data-id=\"3336408\" data-linked=\"Mednax slips 3% on short call by Off Wall Street\" data-tweet=\"$MD - Mednax slips 3% on short call by Off Wall Street https://seekingalpha.com/news/3336408-mednax-slips-3-on-short-call-off-wall-street?source=tweet\" data-url=\"https://seekingalpha.com/news/3336408-mednax-slips-3-on-short-call-off-wall-street\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:22 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336407\" data-ts=\"1520263247\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STRA\" target=\"_blank\">STRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336407-analysts-positive-on-strayer-education\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts positive on Strayer Education</a></h4><ul> <li>Strayer Education (<a href='https://seekingalpha.com/symbol/STRA' title='Strategic Education, Inc.'>STRA</a> <font color='green'>+3.8%</font>) trades higher after landing an upgrade from Piper Jaffray to Overweight.</li> <li>First Analysis also lifts the education stock, moving to Overweight from Equal-weight.</li> <li>Strayer has traded in a 52-week range of $75.84 to $100.72.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3336407\" data-linked=\"Analysts positive on Strayer Education\" data-tweet=\"$STRA - Analysts positive on Strayer Education https://seekingalpha.com/news/3336407-analysts-positive-on-strayer-education?source=tweet\" data-url=\"https://seekingalpha.com/news/3336407-analysts-positive-on-strayer-education\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336405\" data-ts=\"1520262958\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOOG\" target=\"_blank\">GOOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336405-nyt-google-selling-zagat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NYT: Google selling Zagat</a></h4><ul><li>        <a href=\"https://www.nytimes.com/2018/03/05/business/dealbook/zagat-google-infatuation.html?smid=tw-nytimesbusiness&amp;smtyp=cur\" target=\"_blank\">NYT reports</a> Alphabet&rsquo;s (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet, Inc. Cl C'>GOOG</a>, <a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet, Inc. Cl A'>GOOGL</a>) Google will sell Zagat to restaurant review company The Infatuation for an undisclosed amount.</li><li>               The Infatuation will formally announce the deal today. Both companies confirmed the deal.&nbsp;</li><li>               Google bought Zagat in 2011 to integrate the service into its mapping products and redesigned the site and app two years ago.&nbsp;</li><li>               Google Class C shares are&nbsp;<font color='red'>down 0.8%</font>&nbsp;to $1,070.67.&nbsp;&nbsp;</li><li>        Google Class A shares are&nbsp;<font color='red'>down 0.9%</font>&nbsp;to $1,073.90.&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3336405\" data-linked=\"NYT: Google selling Zagat\" data-tweet=\"$GOOG $GOOG $GOOGL - NYT: Google selling Zagat https://seekingalpha.com/news/3336405-nyt-google-selling-zagat?source=tweet\" data-url=\"https://seekingalpha.com/news/3336405-nyt-google-selling-zagat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336404\" data-ts=\"1520262894\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ONTX\" target=\"_blank\">ONTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336404-onconova-out-licenses-rigosertib-to-pint-pharma-for-latin-america\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Onconova out-licenses rigosertib to Pint Pharma for Latin America</a></h4><ul><li>Onconova Therapeutics (<a href='https://seekingalpha.com/symbol/ONTX' title='Onconova Therapeutics'>ONTX</a> <font color='green'>+4.4%</font>) inks an <a href=\"https://seekingalpha.com/pr/17091559-onconova-therapeutics-announces-license-agreement-pint-pharma-commercialize-rigosertib\" target=\"_blank\">agreement </a>with Vienna, Austria-based Pint Pharma GmbH granting the latter exclusive commercialization rights to rigosertib in Latin America.</li><li>Under the terms of the deal, Pint will invest $2.5M in Onconova via the purchase of common shares at a premium to the market, up to $42.75M in milestones and tiered double-digit royalties on net sales.</li></ul><div class=\"tiny-share-widget\" data-id=\"3336404\" data-linked=\"Onconova out-licenses rigosertib to Pint Pharma for Latin America\" data-tweet=\"$ONTX - Onconova out-licenses rigosertib to Pint Pharma for Latin America https://seekingalpha.com/news/3336404-onconova-out-licenses-rigosertib-to-pint-pharma-for-latin-america?source=tweet\" data-url=\"https://seekingalpha.com/news/3336404-onconova-out-licenses-rigosertib-to-pint-pharma-for-latin-america\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336400\" data-ts=\"1520262193\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FL\" target=\"_blank\">FL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336400-foot-locker-takes-back-ground\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Foot Locker takes back some ground</a></h4><ul> <li>Foot Locker (<a href='https://seekingalpha.com/symbol/FL' title='Foot Locker, Inc.'>FL</a> <font color='green'>+2.7%</font>) is clawing back from a double-digit drop on Friday that several analysts are calling overdone.</li> <li>There are price target cuts in today from investment firms Pivotal Research (to $57) and Telsey Advisory (to $49) that are still well above the current $41 trading price for Foot Locker.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3336400\" data-linked=\"Foot Locker takes back some ground\" data-tweet=\"$FL - Foot Locker takes back some ground https://seekingalpha.com/news/3336400-foot-locker-takes-back-ground?source=tweet\" data-url=\"https://seekingalpha.com/news/3336400-foot-locker-takes-back-ground\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336399\" data-ts=\"1520262187\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MSFT\" target=\"_blank\">MSFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336399-microsoft-launching-on-premise-azure-for-governments\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microsoft launching on-premise Azure for governments</a></h4><ul><li>        Microsoft (NASDAQ:<a href='https://seekingalpha.com/symbol/MSFT' title='Microsoft Corporation'>MSFT</a>) says government clients can <a href=\"https://www.reuters.com/article/us-microsoft-azure-government/microsoft-to-offer-governments-local-version-of-azure-cloud-service-idUSKBN1GH28H\" target=\"_blank\">run an on-premise version</a> of its Azure cloud service starting in mid-2018.</li><li>        The offering pairs localized product Azure Stack and Azure Government and would appeal to those needing to store local data for regulatory or logistical reasons, such as military operations or embassies.&nbsp;</li><li>               The launch could push Microsoft&rsquo;s growth in the cloud services market dominated by Amazon Web Services.&nbsp;</li><li>               Last November, Amazon launched AWS Secret Region, a cloud data center region for U.S. intelligence services and government agencies with high-security clearance.&nbsp;</li><li>               Microsoft shares are&nbsp;<font color='red'>down 0.1%</font>&nbsp;to $92.96 to $63.81 to $96.07.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3313564-amazon-launches-aws-region-intelligence-community\" target=\"_blank\">Amazon launches AWS region for intelligence community</a> (Nov. 20, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3336399\" data-linked=\"Microsoft launching on-premise Azure for governments\" data-tweet=\"$MSFT - Microsoft launching on-premise Azure for governments https://seekingalpha.com/news/3336399-microsoft-launching-on-premise-azure-for-governments?source=tweet\" data-url=\"https://seekingalpha.com/news/3336399-microsoft-launching-on-premise-azure-for-governments\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336388\" data-ts=\"1520260519\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LITE\" target=\"_blank\">LITE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336388-needham-calls-lumentum-strong-buy-after-meeting-sees-26-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Needham calls Lumentum Strong Buy after meeting, sees 26% upside</a></h4><ul><li>        Needham <a href=\"https://www.streetinsider.com/Analyst+Comments/Lumentum+Holdings+%28LITE%29%3A+Positive+Company+Visit+-+Needham/13900189.html\" target=\"_blank\">reiterates</a> its Strong Buy rating on Lumentum (NASDAQ:<a href='https://seekingalpha.com/symbol/LITE' title='Lumentum Holdings Inc.'>LITE</a>) after a visit to the company.</li><li>               Analyst Alex Henderson says Lumentum has more visibility in the optical component market than its peers.&nbsp;&nbsp;</li><li>               Henderson says ROADM demand looks solid in 2018 for both the US and China, Pump Laser demand is outstripping supply slightly, and Industrial Lasers is strong with good visibility well into 2H.&nbsp;</li><li>               Firm sets an $80 price target, a 26% upside to Friday&rsquo;s close.&nbsp;</li><li>               Lumentum shares are&nbsp;<font color='green'>up 0.5%</font>&nbsp;to $63.60.&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3336388\" data-linked=\"Needham calls Lumentum Strong Buy after meeting, sees 26% upside\" data-tweet=\"$LITE - Needham calls Lumentum Strong Buy after meeting, sees 26% upside https://seekingalpha.com/news/3336388-needham-calls-lumentum-strong-buy-after-meeting-sees-26-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3336388-needham-calls-lumentum-strong-buy-after-meeting-sees-26-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336381\" data-ts=\"1520259715\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GRPN\" target=\"_blank\">GRPN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336381-grouponplus-1_6-morgan-stanley-lifts-to-neutral\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Groupon +1.6% as Morgan Stanley lifts to Neutral</a></h4><ul>   <li>Groupon (NASDAQ:<a href='https://seekingalpha.com/symbol/GRPN' title='Groupon, Inc.'>GRPN</a>) is <font color='green'>up 1.6%</font> premarket after Morgan Stanley decides a 2018 decline of 16% is overdone and upgrades to Equal Weight.</li>    <li>Shares are trading at about eight times EBITDA, and the company's full-year view of 4-8% growth in EBITDA might be conservative, the firm says. (h/t Bloomberg)</li>    <li>Meanwhile, the company's opex talk suggests gross profit growth will be robust.</li>    <li>The firm has a price target of $4.40, implying about 3% upside.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3336381\" data-linked=\"Groupon +1.6% as Morgan Stanley lifts to Neutral\" data-tweet=\"$GRPN - Groupon +1.6% as Morgan Stanley lifts to Neutral https://seekingalpha.com/news/3336381-grouponplus-1_6-morgan-stanley-lifts-to-neutral?source=tweet\" data-url=\"https://seekingalpha.com/news/3336381-grouponplus-1_6-morgan-stanley-lifts-to-neutral\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336380\" data-ts=\"1520259362\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLSD\" target=\"_blank\">CLSD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336380-premarket-gainers-of-9-05-03-05-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am (03/05/2018)</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/CLSD' title='Clearside Biomedical'>CLSD</a> <font color='green'>+66%</font>&nbsp;as&nbsp;Bio's suprachoroidal CLS-TA <a href=\"https://seekingalpha.com/shark/shark_envelope#menu=marketcurrents#params=type:6\" target=\"_blank\">successful</a> in late-stage uveitis study.</li>     <li><a href='https://seekingalpha.com/symbol/XL' title='XL Group plc'>XL</a> <font color='green'>+30%</font>&nbsp;on being <a href=\"https://seekingalpha.com/news/3336267-axa-acquire-xl-group-15b\" target=\"_blank\">acquired</a> by AXA (<a href='https://seekingalpha.com/symbol/AXAHY' title='AXA ADR'>OTCQX:AXAHY</a>).</li>     <li><a href='https://seekingalpha.com/symbol/GTXI' title='GTx, Inc.'>GTXI</a> <font color='green'>+25%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3336346-premarket-analyst-action-healthcare\" target=\"_blank\">positive</a> analyst action.</li>     <li><a href='https://seekingalpha.com/symbol/ONTX' title='Onconova Therapeutics'>ONTX</a> <font color='green'>+13%</font>&nbsp;as rigosertib <a href=\"https://seekingalpha.com/news/3336325-onconovas-rigosertib-shows-treatment-effect-phase-1-2-mds-study\" target=\"_blank\">shows</a> treatment effect in Phase 1/2 MDS study.</li>     <li>ITUS <font color='green'>+14%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17091344-itus-corporation-forms-alliance-serametrix-corporation\" target=\"_blank\">alliance</a> with Serametrix.</li>     <li><a href='https://seekingalpha.com/symbol/CVRS' title='Corindus Vascular Robotics, Inc.'>CVRS</a> <font color='green'>+14%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3336301-corindus-receives-fda-clearance-first-automated-robotic-movement-techniq-series-corpath-grx\" target=\"_blank\">receiving</a> FDA clearance for first automated robotic movement in technIQ series for CorPath GRX platform.</li>     <li><a href='https://seekingalpha.com/symbol/VCEL' title='Vericel Corporation'>VCEL</a> <font color='green'>+11%</font>&nbsp;on Q4 <a href=\"https://seekingalpha.com/news/3336313-vericel-beats-0_08-beats-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/MYSZ' title='MySize Inc.'>MYSZ</a> <font color='green'>+8%</font>&nbsp;as few <a href=\"https://seekingalpha.com/pr/17091702-sizes-sizeit-smart-measuring-tape-sdk-now-available-android-devices\" target=\"_blank\">application</a> are available&nbsp;for integration with any Android application.</li>     <li><a href='https://seekingalpha.com/symbol/AVGR' title='Avinger'>AVGR</a> <font color='green'>+7%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/ANTH' title='Anthera Pharmaceuticals, Inc.'>OTC:ANTH</a> <font color='green'>+7%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/ADVM' title='Adverum Biotechnologies, Inc.'>ADVM</a> <font color='green'>+6%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/MYO' title='Myomo, Inc.'>MYO</a> <font color='green'>+6%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/AIMT' title='Aimmune Therapeutics'>AIMT</a> <font color='green'>+6%</font>&nbsp;as Nestle (<a href='https://seekingalpha.com/symbol/NSRGY' title='Nestle S.A. ADR'>OTCPK:NSRGY</a>) takes 15% stake.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3336380\" data-linked=\"Premarket Gainers as of 9:05 am (03/05/2018)\" data-tweet=\"$CLSD $CLSD $XL - Premarket Gainers as of 9:05 am (03/05/2018) https://seekingalpha.com/news/3336380-premarket-gainers-of-9-05-03-05-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3336380-premarket-gainers-of-9-05-03-05-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:16 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336378\" data-ts=\"1520259123\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APRN\" target=\"_blank\">APRN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336378-blue-apron-slumps-after-walmart-enters-online-meal-kit-game\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Blue Apron slumps after Walmart enters online meal kit game</a></h4><ul> <li>Shares of Blue Apron (NYSE:<a href='https://seekingalpha.com/symbol/APRN' title='Blue Apron Holdings, Inc.'>APRN</a>) are&nbsp;<font color='red'>down over 4%</font>&nbsp;in premarket trading after Walmart announces that it will sell meal kits through its online grocery pickup program.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3336275-walmart-steps-grocery-war-amazon\" target=\"_blank\">Walmart steps up grocery war with Amazon</a> (March 5)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3336378\" data-linked=\"Blue Apron slumps after Walmart enters online meal kit game\" data-tweet=\"$APRN - Blue Apron slumps after Walmart enters online meal kit game https://seekingalpha.com/news/3336378-blue-apron-slumps-after-walmart-enters-online-meal-kit-game?source=tweet\" data-url=\"https://seekingalpha.com/news/3336378-blue-apron-slumps-after-walmart-enters-online-meal-kit-game\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336377\" data-ts=\"1520258907\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DERM\" target=\"_blank\">DERM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336377-premarket-losers-of-9-05-3-5-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am (3/5/2018)</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/DERM' title='Dermira'>DERM</a>&nbsp;<font color='red'>-63%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3336332-dermiras-olumacostat-glasaretil-flunks-late-stage-studies-acne-vulgaris-shares-halted\" target=\"_blank\">announcing</a> disappointing results from two Phase 3 clinical trials evaluating olumacostat glasaretil in patients with acne vulgaris.</li><li><a href='https://seekingalpha.com/symbol/CEI' title='Camber Energy, Inc.'>CEI</a> <font color='red'>-24%</font>.</li><li><a href='https://seekingalpha.com/symbol/BRFS' title='BRF-Brasil Foods S.A.'>BRFS</a> <font color='red'>-11%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3336377\" data-linked=\"Premarket Losers as of 9:05 am (3/5/2018)\" data-tweet=\"$DERM $DERM $CEI - Premarket Losers as of 9:05 am (3/5/2018) https://seekingalpha.com/news/3336377-premarket-losers-of-9-05-3-5-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3336377-premarket-losers-of-9-05-3-5-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336374\" data-ts=\"1520258713\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IPI\" target=\"_blank\">IPI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336374-fertilizer-stocks-upgraded-cowen-on-game-changing-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fertilizer stocks upgraded at Cowen on &#39;game changing&#39; data</a></h4><ul>     <li>Fertilizer stocks Intrepid Potash (NYSE:<a href='https://seekingalpha.com/symbol/IPI' title='Intrepid Potash, Inc.'>IPI</a>), Mosaic (NYSE:<a href='https://seekingalpha.com/symbol/MOS' title='The Mosaic Company'>MOS</a>), CVR Partners (NYSE:<a href='https://seekingalpha.com/symbol/UAN' title='CVR Partners, LP'>UAN</a>) and CF&nbsp;industries (NYSE:<a href='https://seekingalpha.com/symbol/CF' title='CF Industries Holdings, Inc.'>CF</a>) are upgraded at Cowen, which says meetings with South  American agricultural players have yielded \"game changing\" agriculture  data.</li>     <li>Cowen's Charles Neivert says there seems to be a major crop shortfall in South America, which has not yet showed up in major published sources and will serve as a catalyst to trigger a \"long awaited\" pricing recovery.</li>     <li>Neivert says his recent trip to South America showed an increasingly dire crop situation in Argentina for corn and soybeans, where each crop looks like it will see shortfalls of 10M-15M metric tons of product Y/Y.</li>     <li>The firm raises CF, MOS and UAN to Outperform from Market Perform with respective price targets of $50, $32 and 4.25, and upgrades IPI to Market Perform from Underperform with a $3.75 price target; Nutrien (NYSE:<a href='https://seekingalpha.com/symbol/NTR' title='Nutrien Ltd.'>NTR</a>) is maintained at Outperform with a $60 price target.</li><li>IPI&nbsp;<font color='green'>+6.4%</font>, MOS&nbsp;<font color='green'>+1.6%</font> premarket.</li>     <li>Source:&nbsp;Bloomberg First Word</li> </ul><div class=\"tiny-share-widget\" data-id=\"3336374\" data-linked=\"Fertilizer stocks upgraded at Cowen on &#39;game changing&#39; data\" data-tweet=\"$IPI $IPI $MOS - Fertilizer stocks upgraded at Cowen on &#39;game changing&#39; data https://seekingalpha.com/news/3336374-fertilizer-stocks-upgraded-cowen-on-game-changing-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3336374-fertilizer-stocks-upgraded-cowen-on-game-changing-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336372\" data-ts=\"1520258227\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVGO\" target=\"_blank\">AVGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336372-broadcom-responds-to-cfius-investigation-delayed-qualcomm-meeting\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Broadcom responds to CFIUS investigation, delayed Qualcomm meeting</a></h4><ul><li>        Broadcom (NASDAQ:<a href='https://seekingalpha.com/symbol/AVGO' title='Broadcom Limited'>AVGO</a>) <a href=\"https://seekingalpha.com/pr/17091210-broadcom-disappointed-will-qualcomm-stockholders-deferred\" target=\"_blank\">responds</a> to the CFIUS investigation of its Qualcomm (NASDAQ:<a href='https://seekingalpha.com/symbol/QCOM' title='Qualcomm Inc.'>QCOM</a>) acquisition and the resultant delay of Qualcomm&rsquo;s annual meeting.</li><li>               Key quote: \"Broadcom was informed&nbsp;on Sunday&nbsp;night that on January 29, 2018, Qualcomm secretly filed a voluntary request with CFIUS to initiate an investigation, resulting in a delay of Qualcomm's Annual Meeting 48 hours before it was to take place. This was a blatant, desperate act by Qualcomm to entrench its incumbent board of directors and prevent its own stockholders from voting for Broadcom's independent director nominees.\"&nbsp;</li><li>               Broadcom says it &ldquo;recognizes the important role CFIUS plays in protecting our national security, and is fully committed to cooperating with CFIUS in any review.&rdquo;&nbsp;</li><li>               Last November, Broadcom announced plans to redomicile to the US. The SEC cleared the preliminary proxy statement, and Broadcom expects to complete the process in FY18 Q2, ending May 6. If this happens, the acquisition is no longer covered by CFIUS.&nbsp;</li><li>               Broadcom shares are&nbsp;<font color='red'>down 0.1%</font>&nbsp;premarket to $250.59.</li><li>               Qualcomm shares are&nbsp;<font color='red'>down 1.8%</font>&nbsp;to $63.60.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3336272-cfius-delays-qualcomm-shareholder-meeting\" target=\"_blank\">CFIUS delays Qualcomm shareholder meeting</a> (March 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3336372\" data-linked=\"Broadcom responds to CFIUS investigation, delayed Qualcomm meeting\" data-tweet=\"$AVGO $AVGO $QCOM - Broadcom responds to CFIUS investigation, delayed Qualcomm meeting https://seekingalpha.com/news/3336372-broadcom-responds-to-cfius-investigation-delayed-qualcomm-meeting?source=tweet\" data-url=\"https://seekingalpha.com/news/3336372-broadcom-responds-to-cfius-investigation-delayed-qualcomm-meeting\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>84&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336346\" data-ts=\"1520258079\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EOLS\" target=\"_blank\">EOLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336346-premarket-analyst-action-healthcare\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket analyst action - healthcare</a></h4><ul><li>Evolus (NASDAQ:<a href='https://seekingalpha.com/symbol/EOLS' title='Evolus, Inc.'>EOLS</a>) initiated with an Outperform rating and $20 (75% upside) price target at JMP Securities.Initiated with Buy rating and $24 price target at SunTrust. Initiated with Overweight rating and $25 price target at Cantor Fitzgerald. Initiated with Buy rating and $21 price target at Mizuho Securities.</li><li>MacroGenics (NASDAQ:<a href='https://seekingalpha.com/symbol/MGNX' title='MacroGenics, Inc.'>MGNX</a>) initiated with Buy rating and $38 (31% upside) price target at H.C. Wainwright.</li><li>Revance Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/RVNC' title='Revance Therapeutics, Inc.'>RVNC</a>) initiated with Buy rating and $60 (92% upside) price target at Goldman Sachs.</li><li>Bluebird bio (NASDAQ:<a href='https://seekingalpha.com/symbol/BLUE' title='bluebird bio, Inc.'>BLUE</a>) initiated with Outperform rating at William Blair.</li><li>Valeant Pharmaceuticals (VRX) upgraded to Buy at Deutsche Bank. Shares up&nbsp;<font color='green'>5%</font>&nbsp;premarket.</li><li>GTx (NASDAQ:<a href='https://seekingalpha.com/symbol/GTXI' title='GTx, Inc.'>GTXI</a>) price target raised to $45 (168% upside) at Stifel citing bullish prospects for enobosarm. Shares up&nbsp;<font color='green'>25%</font>&nbsp;premarket.</li><li>Vertex Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/VRTX' title='Vertex Pharmaceuticals Incorporated'>VRTX</a>) price target raised to $200 (18% upside) at Maxim Group following Symdeko approval in U.S.</li><li>Omeros (NASDAQ:<a href='https://seekingalpha.com/symbol/OMER' title='Omeros Corporation'>OMER</a>) downgraded to Hold at Needham citing Omidria uncertainty.</li><li>LifePoint Health (NASDAQ:<a href='https://seekingalpha.com/symbol/LPNT' title='LifePoint Health, Inc.'>LPNT</a>) downgraded to Market Perform at Leerink Partners.</li><li>AMAG Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/AMAG' title='AMAG Pharmaceuticals, Inc.'>AMAG</a>) downgraded to Hold at Jefferies.</li></ul><div class=\"tiny-share-widget\" data-id=\"3336346\" data-linked=\"Premarket analyst action - healthcare\" data-tweet=\"$EOLS $EOLS $MGNX - Premarket analyst action - healthcare https://seekingalpha.com/news/3336346-premarket-analyst-action-healthcare?source=tweet\" data-url=\"https://seekingalpha.com/news/3336346-premarket-analyst-action-healthcare\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336367\" data-ts=\"1520257278\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TDC\" target=\"_blank\">TDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336367-teradata-upgraded-to-slight-downside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Teradata upgraded to slight downside</a></h4><ul><li>        Bernstein <a href=\"https://www.streetinsider.com/Analyst+Comments/Bernstein+Upgrades+Teradata+%28TDC%29+to+Market+Perform/13900257.html\" target=\"_blank\">upgrades</a> Teradata (NYSE:<a href='https://seekingalpha.com/symbol/TDC' title='Teradata Corporation'>TDC</a>) from Underperform to Market Perform and ups the price target by $6 to $39, which is $0.18 below yesterday&rsquo;s close.</li><li>               Analyst Zane Crane forecasts total ARR growth at a 9% CAGR through FY20.&nbsp;</li><li>               Teradata shares are&nbsp;<font color='green'>up 0.5%</font>&nbsp;premarket to $39.38 with a 52-week range of $27.05 to $42.74. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3336367\" data-linked=\"Teradata upgraded to slight downside\" data-tweet=\"$TDC - Teradata upgraded to slight downside https://seekingalpha.com/news/3336367-teradata-upgraded-to-slight-downside?source=tweet\" data-url=\"https://seekingalpha.com/news/3336367-teradata-upgraded-to-slight-downside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336365\" data-ts=\"1520257107\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPA\" target=\"_blank\">SPA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336365-sparton-ultra-electronics-end-merger-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sparton, Ultra Electronics end merger deal</a></h4><ul>     <li>Sparton Corp. (NYSE:<a href='https://seekingalpha.com/symbol/SPA' title='Sparton Corporation'>SPA</a>) <font color='red'>-3%</font> premarket following the <a href=\"https://seekingalpha.com/pr/17091402-sparton-announces-termination-merger-agreement-ultra\" target=\"_blank\">termination of its proposed merger</a> with Ultra Electronics due to anti-trust concerns raised by the U.S. Department of Justice.</li>     <li>SPA says it anticipates that the U.S. Navy will assist in funding the company&rsquo;s transition to independently developing, producing and selling sonobuoys</li>     <li>&ldquo;Ultra had believed that by maintaining two production sites and R&amp;D teams the DoJ would approve the merger, but this was not the case,&rdquo; <a href=\"https://www.reuters.com/article/us-ultra-electronic-results/britains-ultra-electronics-ends-sparton-deal-shares-slump-idUSKBN1GH0V8\" target=\"_blank\">according to</a> analysts at Investec.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3336365\" data-linked=\"Sparton, Ultra Electronics end merger deal\" data-tweet=\"$SPA - Sparton, Ultra Electronics end merger deal https://seekingalpha.com/news/3336365-sparton-ultra-electronics-end-merger-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3336365-sparton-ultra-electronics-end-merger-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>50&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336358\" data-ts=\"1520256945\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLSD\" target=\"_blank\">CLSD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336358-clearside-bios-suprachoroidal-cls-ta-successful-in-late-stage-uveitis-study-shares-ahead-55\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Clearside Bio&#39;s suprachoroidal CLS-TA successful in late-stage uveitis study; shares ahead 55% premarket</a></h4><ul><li>Thinly traded micro cap Clearside Biomedical (NASDAQ:<a href='https://seekingalpha.com/symbol/CLSD' title='Clearside Biomedical'>CLSD</a>) jumps&nbsp;<font color='green'>55%</font>&nbsp;premarket on robust volume in response to its <a href=\"https://seekingalpha.com/pr/17091376-clearside-biomedical-announces-positive-topline-results-pivotal-phase-3-clinical-trial-cls-ta\" target=\"_blank\">announcement </a>of positive results from a Phase 3 clinical trial, PEACHTREE, assessing suprachoroidal CLS-TA (triamcinolone acetonide) in patients with macular edema associated with non-infectious uveitis.</li><li>47% (n=45/96) of patients in the treatment arm gained at least 15 letters in best corrected visual acuity from baseline to week 24 as measured by a scale called ETDRS. The results handily beat sham's (placebo) 16% (p&lt;0.001).</li><li>Detailed results will be submitted for presentation at a future medical conference.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3336213-clearside-bio-announce-phase-3-data-cls-ta-premarket-monday-shares-2-percent-hours\" target=\"_blank\">Clearside Bio to announce Phase 3 data on CLS-TA premarket Monday; shares up 2% after hours</a> (March 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3336358\" data-linked=\"Clearside Bio&#39;s suprachoroidal CLS-TA successful in late-stage uveitis study; shares ahead 55% premarket\" data-tweet=\"$CLSD - Clearside Bio&#39;s suprachoroidal CLS-TA successful in late-stage uveitis study; shares ahead 55% premarket https://seekingalpha.com/news/3336358-clearside-bios-suprachoroidal-cls-ta-successful-in-late-stage-uveitis-study-shares-ahead-55?source=tweet\" data-url=\"https://seekingalpha.com/news/3336358-clearside-bios-suprachoroidal-cls-ta-successful-in-late-stage-uveitis-study-shares-ahead-55\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336361\" data-ts=\"1520256696\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSCO\" target=\"_blank\">TSCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336361-tractor-supply-on-watch-after-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tractor Supply on watch after upgrade</a></h4><ul> <li>Tractor Supply (NASDAQ:<a href='https://seekingalpha.com/symbol/TSCO' title='Tractor Supply Company'>TSCO</a>) is on watch after MoffettNathanson upgrades the retailer to Buy from Neutral.</li> <li>Shares of TSCO are&nbsp;<font color='green'>up 0.44%</font>&nbsp;premarket to $64.50 vs. a 52-week trading range of $49.87 to $82.68.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3336361\" data-linked=\"Tractor Supply on watch after upgrade\" data-tweet=\"$TSCO - Tractor Supply on watch after upgrade https://seekingalpha.com/news/3336361-tractor-supply-on-watch-after-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3336361-tractor-supply-on-watch-after-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336332\" data-ts=\"1520255759\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DERM\" target=\"_blank\">DERM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336332-dermiras-olumacostat-glasaretil-flunks-late-stage-studies-in-acne-vulgaris-shares-halted\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dermira&#39;s olumacostat glasaretil flunks late-stage studies in acne vulgaris; shares halted</a></h4><ul><li>Dermira (NASDAQ:<a href='https://seekingalpha.com/symbol/DERM' title='Dermira'>DERM</a>) is poised for down day after <a href=\"https://seekingalpha.com/pr/17091440-dermira-s-two-phase-3-trials-evaluating-olumacostat-glasaretil-patients-acne-vulgaris-meet-co\" target=\"_blank\">announcing </a>disappointing results from two Phase 3 clinical trials evaluating olumacostat glasaretil (DRM01) in patients at least nine years old with moderate-to-severe acne vulgaris.</li><li>The two studies, CLAREOS-1 and CLAREOS-2, failed to achieve the co-primary endpoints of the absolute change from baseline in inflammatory and non-inflammatory lesion counts and the proportion of subjects achieving at least a two-grade improvement from baseline to a final grade of zero or one in a scale called IGA.</li><li>Based on the information at present, the company says it expects to discontinue the program.</li><li>Shares will resume trading at 8:30 am ET.</li><li>Management will host a conference call this morning also at 8:30 am ET to discuss the results.</li><li><strong>Update</strong>: Shares are down&nbsp;<font color='red'>65%</font>&nbsp;premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3336332\" data-linked=\"Dermira&#39;s olumacostat glasaretil flunks late-stage studies in acne vulgaris; shares halted\" data-tweet=\"$DERM - Dermira&#39;s olumacostat glasaretil flunks late-stage studies in acne vulgaris; shares halted https://seekingalpha.com/news/3336332-dermiras-olumacostat-glasaretil-flunks-late-stage-studies-in-acne-vulgaris-shares-halted?source=tweet\" data-url=\"https://seekingalpha.com/news/3336332-dermiras-olumacostat-glasaretil-flunks-late-stage-studies-in-acne-vulgaris-shares-halted\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3336330\" data-ts=\"1520255419\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZYNE\" target=\"_blank\">ZYNE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3336330-zynerba-pharmaceuticals-announces-positive-meeting-fda-and-plans-to-conduct-single-pivotal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zynerba Pharmaceuticals announces positive meeting with FDA and plans to conduct a single pivotal study of ZYN002 in FXS</a></h4><ul><li>Zynerba Pharmaceuticals&nbsp;(NASDAQ:<a href='https://seekingalpha.com/symbol/ZYNE' title='Zynerba Pharmaceuticals'>ZYNE</a>) <a href=\"https://seekingalpha.com/pr/17091293-zynerba-pharmaceuticals-announces-positive-meeting-u-s-food-drug-administration-plans-conduct\" target=\"_blank\">announces</a> the results of a positive meeting held with the FDA regarding its planned development strategy for ZYN002 in Fragile X syndrome &#40;FXS&#41;.</li>   <li>ZYN002, an Orphan Drug designation&nbsp;is the first and only pharmaceutically-produced cannabidiol &#40;CBD&#41; formulated as a patent-protected permeation-enhanced transdermal gel. It is&nbsp;used as a treatment of FXS.</li>  <li>The Company expects to initiate a single pivotal 14-week randomized, placebo controlled clinical trial in ~200 pediatric and adolescent patients in mid-year 2018 to support a New Drug Application &#40;NDA&#41; for ZYN002 in FXS.</li><li>The primary and key secondary endpoints for the study should assess observable behaviors in patients with FXS as reported by the caregiver using the validated Aberrant Behavior Checklist in Fragile X syndrome (ABC-FXS).</li><li>FXS is a rare genetic developmental disability that is the leading known cause of both inherited intellectual disability and autism spectrum disorder.</li><li>Shares are up&nbsp;<font color='green'>8%</font>&nbsp;premarket on light volume.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3336330\" data-linked=\"Zynerba Pharmaceuticals announces positive meeting with FDA and plans to conduct a single pivotal study of ZYN002 in FXS\" data-tweet=\"$ZYNE - Zynerba Pharmaceuticals announces positive meeting with FDA and plans to conduct a single pivotal study of ZYN002 in FXS https://seekingalpha.com/news/3336330-zynerba-pharmaceuticals-announces-positive-meeting-fda-and-plans-to-conduct-single-pivotal?source=tweet\" data-url=\"https://seekingalpha.com/news/3336330-zynerba-pharmaceuticals-announces-positive-meeting-fda-and-plans-to-conduct-single-pivotal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}